literature review of pharmacy management system pdf

Pharmacy Management Systems

• First Online: 01 January 2012

Cite this chapter

• Stephen Goundrey-Smith MSc. Cert Clin Pharm, MRPharmS 2  

Part of the book series: Health Informatics ((HI))

2070 Accesses

3 Citations

The development of pharmacy systems to support working processes in both hospital and community pharmacy has taken place over the last 40 years in the UK, US and other countries. For the purposes of this chapter, pharmacy systems are defined as computer systems designed specifically for pharmacy departmental use, with functionality for the management of pharmacy and dispensing processes, such as medicine labelling , patient medication records , decision support for drug interactions and other warnings, stock control , ward inventory management, order processing and functions to support pharmacy manufacturing processes in hospitals. Pharmacy systems are often referred to as pharmacy information systems in healthcare provider organisations in the United States, or as patient medication record (PMR) systems in UK community/retail pharmacy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save.

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime
• Available as PDF
• Read on any device
• Instant download
• Own it forever
• Available as EPUB and PDF
• Compact, lightweight edition
• Dispatched in 3 to 5 business days
• Free shipping worldwide - see info
• Durable hardcover edition

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Borggren L. Computers in pharmacy: improve efficiency and productivity. Comput Healthcare. 1984;5(7):39–40.

CAS   Google Scholar  

Moore TD, et al. The pharmacy computer system at the Ohio State University Hospital. Am J Hosp Pharm. 1984;41(11):2384–9.

PubMed   CAS   Google Scholar  

Gouveia WA, et al. The pharmacy computer system at the New England Medical Center. Am J Hosp Pharm. 1984;41(9):1813–23.

Burleson K. Review of computer applications in institutional pharmacy – 1975–1981. Am J Hosp Pharm. 1982;39:53–70.

Knight JR, Conrad WF. Review of computer applications in hospital pharmacy practice. Am J Hosp Pharm. 1975;32(2):165–73.

Stroup J. Hospital pharmacy computer systems: request for proposal and the selection process. Can J Hosp Pharm. 1987;40(3):86–90.

Aldridge GK, MacIsaac D, et al. Managing the implementation of a pharmacy information system. Am J Hosp Pharm. 1993;50(6):1198–203.

Mildenberger J, Gouveia WA, et al. Managing the implementation of a pharmacy computer system. Am J Hosp Pharm. 1982;39(10):1692–701.

Goundrey-Smith SJ. Principles of electronic prescribing. London: Springer Science; 2008. p. 29.

Book   Google Scholar  

Anderson S. Making medicines. London: Pharmaceutical Press; 2005. p. 143.

Google Scholar  

Taheri L. Completing the prescription process in a virtual world – EPS release 2. Pharm J. 2009;283:175–6.

Westerling AM, Haikala VE, et al. Logistics or patient care: which features do independent Finnish pharmacy owners prioritize in a strategic plan for future information technology systems? J Am Pharm Assoc. 2010;50:24–31.

Article   Google Scholar  

Barber N. Electronic prescribing – safer, faster, better? J Health Serv Res Policy. 2010;15 Suppl 1:64–7.

Article   PubMed   Google Scholar  

Kirking DM, Ascione FJ, et al. Relationships between computer use and pharmacists’ professional behavior. Drug Intell Clin Pharm. 1984;18:319–23.

Marriott J, Curtis C, et al. The influence of electronic prescribing on pharmacist clinical intervention reporting. Int J Pharm Pract. 2004;12(Suppl):R44.

See http://www.psnc.org.uk/pages/itsuppliers.html Accessed on Feb 2012.

England and Wales contracted pharmacy services may be found at http://www.psnc.org.uk/pages/introduction.html Accessed on Feb 2012.

Hackett M. Homecare medicines: towards a vision for the future. England Department of Health. 2010. p. 6–18. http://cmu.dh.gov.uk/homecare-medicines-review-group . Accessed on Feb 2012.

Davies A. Presented at the Guild of Healthcare Pharmacists/United Kingdom Clinical Pharmacy Association Information Technology Interest Group (ITIG) Seminar, Oct 2010, Birmingham. http://www.ghp.org.uk/ContentFiles/ghpitig10a.pps

Richman C. How to get useful information out of drug reports – and save time. Clin Pharm. 2011;3:186–8.

Schiff GD, Klass D, et al. Linking laboratory and pharmacy: opportunities for reducing errors and improving care. Arch Intern Med. 2003;163:893–900.

Royal Pharmaceutical Society. Guidance on pharmacy computer systems. London: Royal Pharmaceutical Society; 2003.

Sikora RG, Kotzan JA. Analysis of the change in work patterns following installation of an inpatient pharmacy computer system. Contemp Pharm Pract. 1981;4:160–6.

Crootof LM, Veal JH, et al. Pharmacy information system for a health maintenance organization. Am J Hosp Pharm. 1975;32:1058–62.

Scullin C, Hogg A, et al. Integrated medicines management – can routine implementation improve quality? J Eval Clin Pract. 2011. doi: 10.1111/j.1365–2753.2011.01682.x .

Glintborg B, Poulsen HE, et al. The use of nationwide on-line prescription records improves the drug history in hospitalised patients. Br J Clin Pharmacol. 2008;65:265–9.

Mabotuwana T, Warren J, et al. What can primary care dispensing data tell us about individual adherence to long-term medication? Comparison to pharmacy dispensing data. Pharmacoepidemiol Drug Saf. 2009;18:956–64.

Floor SA, de Smet PA, et al. Documentation quality in community pharmacy: completeness of electronic patient records after patients’ first visits. Ann Pharmacother. 2009;43(11):1787–94.

Lau HS, Florax C, et al. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol. 2006;49(6):597–603.

Rahimtoola H, Timmers A, et al. An evaluation of community pharmacy records in the development of pharmaceutical care in the Netherlands. Pharm World Sci. 1997;19:105–13.

Article   PubMed   CAS   Google Scholar  

Buurma H, De Smet PA, et al. Disease and intolerability documentation in electronic patient records. Ann Pharmacother. 2005;39:1640–6.

Saverno KR, Hines LE, et al. Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions. J Am Med Inform Assoc. 2011;18:32–7.

Hines LE, Saverno KR, et al. Pharmacists’ awareness of clinical decision support in pharmacy information systems: an exploratory evaluation. Res Social Adm Pharm. 2011;7:359–68.

Simonaitis L, Belsito A et al. Aggregation of pharmacy dispensing data into a unified patient medication history. AMIA Annu Symp Proc. 2008;6:1135.

RCGP Informatics Group. Shared record professional guidance report. 2009. http://www.rcgp.org.uk/pdf/Health_Informatics_SRPG_final_report.pdf Accessed on Feb 2012.

Adcock H. Electronic solution to intervention monitoring aids clinical governance. Hosp Pharm. 2006;13:137.

Nurgat ZA, Al-Jazairi AS, et al. Documenting clinical pharmacist intervention before and after the introduction of a web-based tool. Int J Clin Pharm. 2011;33(2):200–7.

Bates DW, Leape L, et al. Effect of computerised physician order entry and a team intervention on prevention of serious medication errors. J Am Med Assoc. 1998;280:1311–6.

Article   CAS   Google Scholar  

Miller RA, Gardner RM, Johnson KB, Hripcsak G. Clinical decision support and electronic prescribing systems: a time for responsible thought and action. J Am Med Inform Assoc. 2005;12:403–9.

Farrar K. Accountability, prescribing and hospital pharmacy in an electronic, automated age. Pharm J. 1999;263:496–501.

Curtis C, Ford NG. Paperless electronic prescribing in a district general hospital. Pharm J. 1997;259:734–5.

Barker A, Kay J. Electronic prescribing improves patient safety – an audit. Hosp Pharm. 2007;14:225.

Slee A E-prescribing in Birmingham. Presented at the Guild of Healthcare Pharmacists/United Kingdom Clinical Pharmacy Association Information Technology Interest Group (ITIG) Seminar, Oct 2010, Birmingham. http://www.ghp.org.uk/ContentFiles/ghpitig10a.pps Accessed on Feb 2012.

Download references

Author information

Authors and affiliations.

SGS Pharma Solutions, Chedworth, Gloucestershire, UK

Stephen Goundrey-Smith MSc. Cert Clin Pharm, MRPharmS

You can also search for this author in PubMed   Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Goundrey-Smith, S. (2013). Pharmacy Management Systems. In: Information Technology in Pharmacy. Health Informatics. Springer, London. https://doi.org/10.1007/978-1-4471-2780-2_6

Download citation

DOI : https://doi.org/10.1007/978-1-4471-2780-2_6

Published : 08 July 2012

Publisher Name : Springer, London

Print ISBN : 978-1-4471-2779-6

Online ISBN : 978-1-4471-2780-2

eBook Packages : Medicine Medicine (R0)

Share this chapter

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Publish with us

Policies and ethics

• Find a journal
• Track your research

Pharmacy Students: Year 3

• Home and Help
• 567: Pharmacy Law
• 608: Therapeutics: Oncology and Immune Disorders
• 610: Therapeutics: Special Populations
• 611: Therapeutics: Infectious Diseases
• 619: Therapeutics: Cardiovascular System
• 620/621: Practice and Professionalism
• 622/623: Case Conference
• 633: Pharmacy Management and Economics
• 650: APPE Gateway
• Develop a Question
• Literature Review
• Data Management
• IRB and CITI
• Make a Poster
• Cannabis User Safety (pharmacy elective)
• Community Pharmacy and Business Management (pharmacy elective)
• Geriatric Pharmacy (pharmacy elective)
• Global Pharmacy (pharmacy elective)
• Interprofessional Education (pharmacy electives)
• Marketing and Development in the Pharmaceutical Industry (pharmacy elective)
• Pharmaceutical Bioinformatics (pharmacy elective)
• Pharmaceutical Development (pharmacy elective)
• Pharmacy Education (pharmacy electives)
• Spanish for Pharmacists (pharmacy elective)
• Sports Pharmacy (pharmacy electives)
• Toxicology and the Media (pharmacy elective)
• Research Resources
• Spanish for Health Care Professionals
• Career Resources
• Drug Information

Why do a literature review?

A literature review is an essential part of the research process. By conducting a review-- searching for and reading articles-- it helps you to understand who else has worked on your topic, methods that have been used to investigate this topic, and results/outcomes from similar studies, and develop your own research questions. When writing a literature review, you selective choose some of the readings you identified during your exploration, and write a short paragraph to prove to readers that your research question is necessary, important, and unanswered.

You do not need to conduct a Systematic Review. A Systematic Review is a research methodology where you attempt to gather all relevant literature describing a narrowly defined question. You may use a systematic technique to ensure you have searched relevant databases thoroughly, but your literature review does not need to be as extensive as a Systematic Review.

For a literature review, expect:

- That you will read two articles or book chapters for every one included in your final written review.

- You will need to search 2-6 subject-specific databases containing articles, book chapters, dissertations/theses, and other scholarly output. This typically happens at the start of the review.

- Your goal is to be thorough: expect to use both keywords and indexing terms to search databases

- You may need to use statistical sources, newspaper articles, articles from popular press magazines, reports from government organizations, or other types of unique sources in your review. These are unlikely to be a major part of your literature review, but can help to prove that a problem is widespread and deserving of research attention.

Process of a literature review

1. Define your question-- develop a hypothesis or research question.  For example, "If we teach nurses to use asthma puffers correctly, does this increase patient-reported compliance with use of puffers and increase the rate of refills?"

2. Consider which databases would best provide information on your topic. Databases tend to focus on disciplines or subjects. If your research is about clinical use of drugs, you may only need to use clinically-focused databases. If your research concerns motivation for behavior, you may want to use psychology databases. If your research question is about economics of drugs, you may want to use business/economics-focused databases. Use this list of databases on this page or talk to a librarian to find the best databases for researching your question.

2. Break apart your question into concepts. With the question above, major concepts include nurses, asthma puffers, drug compliance, technique, refills.

3. For each concept, brainstorm synonyms. For example, puffer= inhaler, Flovent (or other brand names), etc.

3a. If using an indexed database like PubMed, look for the preferred indexing term for each concept and add it to your synonym list.

4. Combine the synonyms in your database. Use OR to connect synonyms. Use AND to connect different concepts. For example: (Nurse OR nurses) AND (inhaler OR puffer) AND (education OR training OR instruction).

4a. It is sometimes easier to look for research covering parts of your question rather than the whole. It is unlikely that there has been research on exactly your topic (nurses, and asthma puffers, and instruction, and compliance, and refills). Consider looking for research on nurses and inhalers; instruction with inhalers and if that affects patient compliance; use of puffers and refill rates; or other ways to break down the question into smaller parts.

5. Examine the results in your first database by reading the abstracts. Add to your list of synonyms by seeing what terms are used in the abstracts, and consider re-running the search with additional terms. Create a list of materials from this database that seem relevant. Next, download the full text of articles, book chapters, etc. on your list. Get older articles in print from the library's print collections. Repeat this process in your other databases.

6. Read the materials you found in step 5. Consider whether the information you have found allows you to demonstrate:

• That your topic is relevant and important, and deserves you and your group spending a year in investigating it.
• That you have found articles that cover a relevant timeframe and scope for your question.
• That you have seen any landmark studies, or major studies that have changed thinking on a topic. Not every topic area has landmark studies.
• That you can summarize the research methods that have been used to study this question/problem before and their results.

7. If you cannot demonstrate each of these, repeat steps 4 and 5 until you can.

8. Write your literature review, summarizing why your question/problem is important, other methods that have been used to investigate this problem and what they have found, and explain why your research question will help fill gaps in current knowledge. You can consider using the FINER criteria (Feasible, Interesting, Novel, Ethical, Relevant) to ensure you have covered the key aspects of the topic in enough depth. You will likely cite/reference about half the items you read. Your goal here is to select enough materials to demonstrate that you know this topic, without overwhelming your audience.

Help on literature reviews

• Bailey's Research for the Health Professional, 3rd ed ISBN: 9780803645134 Includes detailed help on literature reviews

Databases to use

USC subscribes to over 1300 databases, so only the primary databases you may use are listed here. If these do not cover your topic fully, examine the A-Z list of databases and read descriptions, or ask a librarian for help.

• Databases licensed by USC Libraries This link opens in a new window A-Z list of all databases licensed by USC Libraries.

Clinical databases

• CINAHL Complete This link opens in a new window Most comprehensive database of full-text for nursing & allied health journals from 1937 to present. Includes access to scholarly journal articles, dissertations, magazines, pamphlets, evidence-based care sheets, books, and research instruments.
• Embase This link opens in a new window Embase provides access to over more than 29 million citations for biomedical articles and conference proceedings. This version has been customized for USC users to find the full-text of articles from library holdings.

Basic sciences databases

• Biosis Citation Index This link opens in a new window Life sciences and biomedical research database covering pre-clinical and experimental research, methods and instrumentation, animal studies, and more.
• International Pharmaceutical Abstracts (Ovid) This link opens in a new window Worldwide coverage of pharmaceutical science and practice literature. Includes coverage of drug development, pharmacoeconomics, toxicity, regulation, and technology.
• SciFinder This link opens in a new window Articles, patents, and white papers describing chemicals. Includes information on structures, reactions, compounds, drug development, and manufacturing. Requires separate login. Go to USC's create an account page to register.

Social Sciences databases

• ERIC (ProQuest) This link opens in a new window Education focused database.
• Global Health This link opens in a new window Public health database, focus on international coverage.
• PsycINFO This link opens in a new window Abstract and citation database of scholarly literature in psychological, social, behavioral, and health sciences. Includes journal articles, books, reports, theses, and dissertations from 1806 to present.
• EconLit This link opens in a new window Literature in economics.

General Databases These databases include multiple subjects. They are useful databases for looking for landmark studies; determining if your topic is well-studied by another subject (as this would lead you to select a database that focuses on just that subject); and ensuring you did not miss research published in prominent scientific journals.

• Scopus This link opens in a new window Large abstract and citation database of peer-reviewed literature in science, technology, medicine, social sciences, and arts and humanities. Includes bibliometrics tools to track, analyze and visualize research.
• Web of Science This link opens in a new window
• Google Scholar This link opens in a new window Filtered Google Search finding scholarly journal articles, books, citations, and case law.

Writing & Citing Help

Use these handouts to get information on citing and writing; contact the Norris Medical Library with questions. 

• Using Review Articles Review this handout to make sure you're using review articles appropriately.
• Quick Citing Reference- AMA 11th ed 2 page handout covering the basics of using AMA style, 11th edition
• << Previous: Develop a Question
• Next: Data Management >>
• Last Updated: Aug 26, 2024 4:19 PM
• URL: https://libguides.usc.edu/healthsciences/pharmyr3

• Corpus ID: 79386264

Inventory Management in Pharmacy Practice: A Review of Literature

• Published 1 October 2011
• Business, Medicine
• Archives of Pharmacy Practice

Tables from this paper

39 Citations

Pharmacists’ perception on the use of accounting information system for pharmacy management: a study in muscat, oman, inventory management: a tool of identifying items that need greater attention for control, a study to review drug inventory and pharmacy management with reference to i.v. & injectables at a tertiary municipal care hospital with 1800 bedded hospital, the challenges of drug shortages in the canadian hospital pharmacy supply chain — a systematic literature review, inventory control mechanism of the pharmacy store of a recently established national institute in eastern india: a cross-sectional, investigative analysis, designing inventory policy for formula and enteral food in hospital using simulation.

• Highly Influenced

Determining the Optimal Inventory Management Policy for Naval Medical Center San Diego's Pharmacy

• 13 Excerpts

Utilization of Technology to Improve Efficiency in Investigational Drug Management Processes

Assessment of inventory and store management practices of pharmaceuticals in public health centers and hospitals of dessie town, ethiopia, identification of indicators for evaluating the financial and economic performance of the pharmacy: a systematic review, 12 references, automation in drug inventory management saves personnel time and budget., a review of limited lists and formularies: are they cost-effective, pharmacy management: essentials for all practice settings., purchasing and inventory control, a continued look into the financial implications of initial noncompliance in community pharmacies: an unclaimed prescription audit pilot.

• Highly Influential

The American Society of Health System Pharmacists.

Related papers.

Showing 1 through 3 of 0 Related Papers

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Elsevier - PMC COVID-19 Collection

Research Designs and Methodologies Related to Pharmacy Practice

The need for evidence to inform policy and practice in pharmacy is becoming increasingly important. In parallel, clinical pharmacy and practice research is evolving. Research evidence should be used to identify new areas for improved health service delivery and rigorously evaluate new services in pharmacy. The generation of such evidence through practice-based research should be predicated on appropriate use of robust and rigorous methodologies. In addition to the quantitative and qualitative approaches used in pharmacy practice research, mixed methods and other novel approaches are increasingly being applied in pharmacy practice research. Approaches such as discrete choice experiments, Delphi techniques, and simulated client technique are now commonly used in pharmacy practice research. Therefore, pharmacy practice researchers need to be competent in the selection, application, and interpretation of these methodological and analytical approaches. This chapter focuses on introducing traditional and novel study designs and methodologies that are particularly pertinent to contemporary clinical pharmacy and practice research. This chapter will introduce the fundamentals and structures of these methodologies, but more details regarding the different approaches may be found within the Encyclopedia.

Learning Objectives

• • Discuss the value of pharmacy practice research to evidence-based practice and policy.
• • Describe the classifications and types of study designs commonly used in pharmacy practice research.
• • Discuss the concepts and structure of common study designs used in pharmacy practice research including experimental, quasi-experimental, observational, qualitative, and mixed method designs.
• • Discuss the important considerations for conducting pharmacy practice research in terms of study design, data collection, data analyses, and ethical considerations.

Introduction to Research Methodologies Used in Pharmacy Practice

The mission of pharmacy profession and the role of pharmacists in healthcare have evolved toward patient-centered care in the last few decades. Pharmacists with their expertise in drug therapy and accessibility to the public have unprecedented opportunities to assume increasing responsibility for direct patient care ( Bond, 2006 ). New cognitive pharmaceutical services and new roles for pharmacists continue to emerge.

In the era of evidence-based practice and health services, it is not just adequate to propose those new pharmacy services or new roles without evidence of their benefit ( Awaisu and Alsalimy, 2015 , Bond, 2006 ). New pharmacy services and new roles must be proven to be feasible, acceptable, cost-effective, and increase health outcomes. Pharmacy practice research provides such evidence and can confirm the value of a new service, inform policy, and result in practice changes ( Bond, 2006 , Chen and Hughes, 2016 ). Research evidence should be used to identify new areas for improved health service delivery and rigorously evaluate new services. The research used to generate such evidence should be grounded in robust and rigorous methodologies ( Chen and Hughes, 2016 ). Traditionally, common quantitative and qualitative methods such as randomized controlled trials, cohort study, case control study, questionnaire-based surveys, and phenomenology using qualitative interviews have been used in pharmacy. However, in recent years, novel and more complex methods are being developed and utilized. Pharmacy practice researchers need to know how these old and new methodological approaches should be selected, applied, and interpreted in addressing research problems.

Various study designs, including, but not limited to experimental, quasi-experimental, observational, qualitative, and mixed method designs, have been used in pharmacy practice research. Furthermore, different classification systems (e.g., quantitative vs. qualitative, experimental vs. observational, descriptive vs. analytical study designs) have been used in the literature. The choice of a study design to answer a research question in pharmacy practice research is driven by several factors, including the type of the research question or the research hypothesis, expertise of the investigator, availability of data, and funding opportunities. Pharmacy practice researchers need to be competent in the selection, design, application, and interpretation of these methodological and analytical approaches. Today, many of the research methods used in pharmacy practice research have been adapted from fields such as sociology, anthropology, psychology, economics, and other disciplines. This paradigm shift has led to a greater emphasis on the appropriate choice of a specific research design or method to answer a specific research question ( Chen and Hughes, 2016 ). Consequently, pharmacy practice researchers should place an emphasis on the reliability of the methods selected, the correct interpretation of their findings, the testing of a specific hypothesis, and the internal validity of their data, among other considerations. Novice and early career researchers should be familiar and have sound foundation in a variety of methods applied in pharmacy practice research, which will be covered in this chapter and other chapters in this Encyclopedia. We do believe that more experienced researchers should focus on certain methods in order to advance research in our discipline.

Core Quantitative and Qualitative Approaches Used in Pharmacy Practice Research

Traditionally, core quantitative approaches used in pharmacy practice research include nonexperiments, quasi-experimental designs, and true experimental designs such as prospective randomized controlled intervention trials. Nonexperiments also include observational study designs that are often described as pharmacoepidemiologic study designs such as case–control study, cohort study, nested case–control study, and cross-sectional study ( Etminan, 2004 , Etminan and Samii, 2004 ). In recent years, conventional qualitative approaches and their philosophical paradigms are increasingly been used in pharmacy. These include the five qualitative approaches to inquiry: narrative research, phenomenology, grounded theory, ethnography, and case study. These qualitative methods are often difficult for pharmacy practice researchers to comprehend, and researchers tend to describe the methods of data collection such as individual interviews and focus group discussions as qualitative methods of inquiry. These data collection methods are briefly described later in this chapter, among others. Furthermore, there is an increasing importance on the appropriate selection and use of mixed method approach ( Hadi et al., 2013 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b ), which are often designed and applied wrongly. Finally, it is worthwhile to be familiar with novel research methodologies such as discrete choice experiments, Delphi techniques, simulated client technique, and nominal group techniques, which fall between quantitative and qualitative approaches, often with no clear differentiation on where they belong. Although called “novel” in the context of this chapter, these methods are not new in other relevant disciplines, but new and not commonly used in pharmacy practice research.

Research Question and Selection of Study Design

Pharmacy practice researchers begin by conception of a research idea or identifying a research question and defining a hypothesis based on the question. The researcher then selects a study design that will be suitable to answer the research question. The study design should be appropriately selected prior to initiation of any research investigation. Selecting an inappropriate study design may potentially undermine the validity of a study in its entirety. Investigators are encouraged to critically think about the possible study designs to ensure that the research question is adequately addressed and should be able to adequately justify their choice. These study designs have been variously classified and one common classification system is quantitative vs. qualitative study designs. Study designs play a major role in determining the scientific value of research studies. Inappropriate choice of a study design is impossible to correct after completion of the study. Therefore, thorough planning is required to avoid unconvincing results and invalid conclusions. Good understanding of basic study design concepts will aid researchers in conducting robust and rigorous practice-based research. This chapter introduces the structure and the fundamentals of common study designs used in pharmacy practice research and discusses the important considerations for conducting pharmacy practice research in terms of study design, data collection, data analyses, and ethical considerations.

Classification of Research Methodologies Used in Pharmacy Practice

Various classifications for research designs and methods used in pharmacy practice have been used in the literature. The following are some of the approaches for the classification of research designs:

Case example: Investigators were looking for the association between acute myocardial infarction and smoking status, type of tobacco, amount of smoke, etc. ( Teo et al., 2006 ). Another example of a case–control study from published literature is the study investigating the association between the use of phenylpropanolamine and the risk of hemorrhagic stroke ( Kernan et al., 2000 ).

Case example: Investigators were interested to determine the long-term effectiveness of influenza vaccines in elderly people; they recruited cohorts of vaccinated and unvaccinated community-dwelling elderly ( Nichol et al., 2007 ).

Case example: A case report was written by a physician who contracted Severe Acute Respiratory Syndrome (SARS) during an outbreak in Hong Kong ( Wu and Sung, 2003 ). Another example is an ecological study examining diet and sunlight as risks for prostate cancer mortality ( Colli and Colli, 2006 ). Chim et al. conducted a large population-based survey in Australia to determine what community members think about the factors that do and should influence government spending on prescribed medicines ( Chim et al., 2017 ).

Case example: A group of investigators carried out a study to establish an association between the use of traditional eye medicines (TEM) and corneal ulcers. In this case, both case–control and cohort study designs are applicable. In an example of a case control study, Archibugi et al. aimed to investigate the association between aspirin and statin exclusive and combined and pancreatic ductal adenocarcinoma occurrence ( Archibugi et al., 2017 ). Another example of a cohort study is a study carried out by Wei et al. in which they investigated whether or not acid-suppression medicines increased the risk of bacterial gastroenteritis ( Wei et al., 2017 ).

Case examples: Investigators conducted a study about the newer versus older antihypertensive agents in African hypertensive patients (NOAAH) trial (nct01030458) to compare the efficacy of single-pill combinations of newer versus older antihypertensive agents (i.e., a single-pill combination of newer drugs, not involving a diuretic, with a combination of older drugs including a diuretic) ( Odili et al., 2012 ). In a crossover design, a group of investigators evaluated the effect of spironolactone on nonresolving central serous chorioretinopathy ( Bousquet et al., 2015 ).

Case examples: Prashanth et al. aimed to understand if (and how) a package of interventions targeting primary health centers and community participation platforms affect utilization and access to generic medicines for people with noncommunicable diseases using quasi-experimental design approach ( Prashanth et al., 2016 ).

• c. Observational design—It involves only observation of natural phenomena and does not involve investigator intervention. Typically, this study design investigates associations and not causation. Examples include cohort study and case–control study. These studies can explore an association between a pharmacologic agent and a disease of interest. Case examples: Please see previous examples of these.

Case examples: Please see experimental studies, and case–control and cohort study designs.

Case examples: Investigators in Canada explored the lived experiences of youth who are prescribed antipsychotics by conducting interpretative phenomenology study ( Murphy et al., 2015 ).

Case examples: Shiyanbola et al. combined focus group discussion with a survey tool to investigate patients' perceived value and use of quality measures in evaluating and choosing community pharmacies ( Shiyanbola and Mort, 2015 ).

Below is a brief description of traditional and novel pharmacoepidemiologic study designs. Several examples of pharmacoepidemiologic study designs are provided above. Some descriptive studies including case reports, case series, and ecological studies will not be described in this chapter.

• a. Case–control studies—In this design, patients (those who develop the disease or outcome of interest) are identified and control patients (those who do not develop the disease or outcome of interest) are sampled at random from the original cohort that gives rise to the cases ( Etminan and Samii, 2004 , Newman et al., 2013 ). The distribution of exposure to certain risk factors between the cases and the controls is then explored, and an odds ratio (OR) is calculated.
• b. Cohort studies—This can be described as a study in which a group of exposed subjects and a group of unexposed subjects are followed over time and the incidence of the disease or outcome of interest in the exposed group is compared with that in the unexposed group ( Etminan and Samii, 2004 , Hulley et al., 2013 ).
• c. Case-crossover studies—The case-crossover may be considered comparable to a crossover randomized controlled trial in which the patients act as their own control ( Etminan and Samii, 2004 ). Pattern of exposure among the cases is compared between event time and control time. The between-patient confounding that occurs in a classic case-control study is circumvented in this design. Tubiana et al. evaluated the role of antibiotic prophylaxis and assessed the relation between invasive dental procedures and oral streptococcal infective endocarditis, using a nationwide population-based cohort and a case-crossover study design ( Tubiana et al., 2017 ).
• d. Case–time control studies—This design is an extension of the case-crossover design, but includes a control group ( Etminan and Samii, 2004 ). A group of researchers assessed medication-related hospitalization. They used the case–time control study design to investigate the associations between 12 high risk medication categories (e.g., antidiabetic agents, diuretics, benzodiazepine hypnotics) and unplanned hospitalizations ( Lin et al., 2017 ).
• e. Nested case–control studies—In this design, a cohort of individuals is followed during certain time periods until a certain outcome is reached and the analysis is conducted as a case–control study in which cases are matched to only a sample of control subjects ( Etminan, 2004 ). de Jong et al. examined the association between interferon-β (IFN-β) and potential adverse events using population-based health administrative data in Canada ( De Jong et al., 2017 ).
• f. Cross-sectional studies—In this type of study, the investigator measures the outcome of interest and the exposures among the study participants at the same time ( Hulley et al., 2013 , Setia, 2016b ). It provides a snapshot of a situation for a particular period.

Quantitative Research Designs in Pharmacy Practice

A wide range of quantitative methods are commonly applied in pharmacy practice research. These methods are widely used in published pharmacy practice literature to explore appropriateness of medicines use, appropriateness and quality of prescribing, and medication safety, through analyzing existing datasets, direct observation, or self-report ( Green and Norris, 2015 ). Pharmacy practice research questions also seek to determine the knowledge, behaviors, attitudes, and practices of pharmacists, other healthcare providers, patients, policy-makers, regulators, and the general public. Quantitative methods are also used in evaluating the effect of new pharmacy services and interventions to improve medicines use. These practice research projects provide valuable insights about how medicines are used, and how to maximize their benefits and minimize their harmful effects. In the context of this chapter, quantitative study designs will be broadly classified into three: (1) observational, (2) experimental and quasi experimental, and (3) other designs.

Observational Study Designs

Pharmacoepidemiology is a “relatively new science that explores drug efficacy or toxicity using large observational study designs” ( Etminan, 2004 , Etminan and Samii, 2004 ). These study designs explore drug use studies that usually cannot be answered using randomized controlled trials or other experimental designs. In several instances, experimental study designs may not be suitable or feasible; in such circumstances, observational study designs are applied ( Cummings et al., 2013 ). As the name implies, observational studies involve merely observing the subjects in a noncontrolled setting, without investigator intervention or manipulating other aspects of the study. Therefore, observational studies are nonexperimental. The observation of the variables of interest can be prospective, retrospective, or current depending on the type of the observational study.

In pharmacoepidemiology and other areas of pharmacy practice, researchers are often interested in measuring the relationships between exposure to a drug and its efficacy, toxicity, or other outcomes of interest using observational study designs. It is worthwhile to note that observational study designs investigate association, but, in most cases, not causation. Here, we provide descriptions of some commonly used study designs in pharmacoepidemiology and pharmacy practice research in general.

Case–Control Studies

Case–control study design is used to determine association between risk factors or exposures and outcomes. It is a useful design to study exposures in rare diseases or diseases that take long time to develop ( Newman et al., 2013 ). It investigates exposures in individuals with and those without the outcome of interest. Nevertheless, case–control studies can help to identify harmful or beneficial exposures. Furthermore, the outcome of interest can be undesirable (e.g., mortality) or desirable (e.g., microbiological cure). As the name suggests, in a case–control study design, there are two groups of subjects: (1) cases (individuals with the outcome of interest) and (2) controls (individuals without the outcome of interest) ( Newman et al., 2013 ). Cases are randomly selected based on prespecified eligibility criteria from a population of interest. Appropriate representative controls for the cases selected are then identified. The researchers then retrospectively investigate possible exposures to the risk factor. Fig. 1 represents a schematic diagram of a case–control study.

Case–control study design.

Case–control studies are relatively inexpensive, less time-consuming to conduct, allow investigation of several possible exposures or associations, and are suitable for rare diseases. Selection of the control group is a critical component of case–control studies. Case–control studies have several drawbacks: confounding must be controlled, subject to recall, observation, and selection biases.

OR is the measure of association used for the analysis of case–control studies. This is defined as the odds of exposure to a factor in those with a condition or disease compared with those who do not have the condition or disease.

Cohort Studies

Similar to case–control studies, cohort studies determine an association between exposures/factors and development of an outcome of interest. As previously described, a cohort study is a study in which a group of exposed subjects and a group of unexposed subjects are followed over time to measure and compare the rate of a disease or an outcome of interest in both groups ( Etminan and Samii, 2004 , Hulley et al., 2013 ). A cohort study can be prospective (most common) or retrospective. While a case–control study begins with patients with and those without the outcome of interest (e.g., diseased and nondiseased patients), a cohort study begins with exposed and unexposed patients (e.g., patients with and those without certain risk factor) ( Hulley et al., 2013 , Setia, 2016a ). In a cohort study, both the exposed and the unexposed subjects are members of a larger cohort in which subjects may enter and exit the cohort at different periods in time ( Etminan and Samii, 2004 , Hulley et al., 2013 ).

Typically, a cohort study should have a defined time zero, which is defined as the time of entry into the cohort ( Etminan and Samii, 2004 ). The cohort (a group of exposed and unexposed subjects, who are free of the outcome at time zero) is followed for a certain period until the outcome of interest occurs. In addition, information or data related to all potential confounders or covariates should also be collected as failure to account for these can bias the results and over- or underestimates the risk estimate. There are two types of cohort studies: retrospective cohort and prospective cohort studies.

Retrospective cohort study, also known as historical cohort study, begins and ends in the present, while looking backward to collect information about exposure that occurred in the past ( Fig. 2 ). Historical cohort studies are relatively less time-consuming and less expensive than prospective cohort studies ( Etminan and Samii, 2004 , Hulley et al., 2013 , Setia, 2016a ). In addition, there is no loss to follow-up and researchers can investigate issues not amenable to intervention study designs. However, these studies are only as good as the data available, the investigator has limited control of confounding variables, and it is prone to recall bias.

Retrospective (historical) cohort study design.

On the other hand, prospective cohort study, also known as longitudinal cohort study, begins in the present and progresses forward, collecting data from enrolled subjects whose outcomes fall in the future ( Etminan and Samii, 2004 , Hulley et al., 2013 , Setia, 2016a ) ( Fig. 3 ). Prospective cohort studies are easier to plan for data collection, have low recall bias, and the researcher has a better control of confounding factors. On the other hand, it is difficult to study rare conditions; they are more prone to selection bias, more time-consuming, expensive, and loss of subjects to follow-up is common.

Prospective (longitudinal) cohort study design.

Relative risk (RR) is the measure of association used for the analysis of a cohort study. This is defined as the risk of an event or development of an event relative to exposure (i.e., the risk of subjects developing a condition when exposed to a risk factor compared with subjects who have not been exposed to the risk factor).

Case-Crossover Studies

This is a relatively new design in the field of epidemiology in which the patients act as their own controls ( Maclure, 1991 ). In this design, there is a case and a control element both of which come from the same subject. In other words, each case serves as its own control. It can be considered equivalent to a crossover RCT with a washout period ( Etminan and Samii, 2004 ). Pattern of exposure to the risk factor is compared between the event time and the control time ( Etminan and Samii, 2004 ). Case-crossover study design is useful to investigate triggers within an individual. For instance, it is applicable when studying a transient exposure or risk factor. However, determination of the period of the control and case components is a crucial and challenging aspect of a case-crossover study design. Since the patients serve as their own controls, the interindividual variability that is inherent in classic case–control studies is eliminated. This is important in studies involving progressive disease states in which disease severity may differ between patients such as multiple sclerosis. OR is estimated using techniques such as Mantel–Haenszel statistics and logistic regression.

Cross-Sectional Studies

Cross-sectional studies also known as prevalence studies identify the prevalence or characteristics of a condition in a group of individuals. This design provides a snapshot of the prevalence or the characteristics of the study subjects in a single time point. The study investigator measures the outcomes and the exposures in the study subjects simultaneously ( Etminan and Samii, 2004 , Hulley et al., 2013 , Setia, 2016b ). Hence, cross-sectional studies do not follow up patients to observe outcomes or exposures of interest. Data are often collected through surveys. Cross-sectional design cannot provide cause and effect relationships between certain exposures and outcomes of interest.

Experimental and Quasi-Experimental Study Designs

In a typical experimental study design, the investigator assigns subjects to the intervention and control/comparison groups in an effort to determine the effects of the intervention ( Cummings et al., 2013 ). Since the investigator has the opportunity to control various aspects of the experiment, this allows the researcher to determine the causal link between exposure to the intervention and outcome of interest. The researcher either randomly or conveniently assigns the subjects to an experimental group and a control group. When the investigator performs randomization, the study is considered a true experiment (see Fig. 4 ). On the other hand, if subjects are assigned into groups without randomization, the study is considered a quasi-experiment (refer to Fig. 5 ). As with experimental designs, quasi-experimental designs also attempt to demonstrate a causal link between the intervention and the outcome of interest. Due to the challenges of conducting a true experimental design, the quasi-experimental study designs have been consistently used in pharmacist intervention research.

True experimental study design.

Quasi experimental study design.

RCTs are considered the gold standard of experimental study designs in pharmacy practice and evidence-based research ( Cummings et al., 2013 ). The investigator randomly assigns a representative sample of the study population into an experimental group and a control group ( Fig. 4 ). Randomization in RCT is to minimize confounding and selection bias; it enables attainment of similar experimental and control groups, thereby isolating the effect of the intervention. The experimental group receives the treatment or intervention (e.g., a new drug or pharmaceutical care for treatment of a certain disease), while the control group receives a placebo treatment, no treatment, or usual care treatment depending on the objective of the study ( Cummings et al., 2013 ). These groups are then followed prospectively over time to observe the outcomes of interest that are hypothesized to be affected by the treatment or intervention. The result of the study is considered to have high internal validity if significant changes on the outcome variable occur in the experimental group, but not the control group. The investigator can infer that the treatment or intervention is the most probable cause of the changes observed in the intervention group. The unit of randomization in RCTs is usually the patient, but can sometimes be clusters to circumvent the drawbacks of contamination.

RCTs are very challenging to undertake and pharmacy practice researchers should ensure design of robust experiments, while considering all essential elements and adhering to best practices. For instance, to determine the impact of a cognitive pharmaceutical service, the selection of a representative sample of the population is a prime consideration in an RCT. Moreover, RCTs are expensive, labor-intensive, and highly prone to attrition bias or loss to follow-up.

In pharmacy practice research, it is often difficult to comply with the stringent requirements of true experimental designs such as RCTs, due to logistic reasons and/or ethical considerations ( Grady et al., 2013 , Krass, 2016 ). Whenever true experimental models are not feasible to be applied in pharmacy practice research, the researcher should endeavor to use a more robust quasi-experimental design. For instance, when randomization is not feasible, the researcher can choose from a range of quasi-experimental designs that are non-randomized and often noncontrolled ( Grady et al., 2013 , Krass, 2016 ). Quasi-experimental studies used in pharmacy literature may be classified into five major categories: (1) quasi-experimental design without control groups (i.e., one group pre–posttest design); (2) quasi-experimental design that use control groups with no pretest; (3) quasi-experimental design that use control groups and pretests (i.e., nonequivalent control group design with dependent pretests and posttests) (see Fig. 5 ); (4) interrupted time series and; (5) stepped wedge designs ( Brown and Lilford, 2006 , Grady et al., 2013 , Harris et al., 2006 ).

The one group pretest posttest design and the nonequivalent control group design ( Fig. 5 ) are the most commonly applied quasi-experimental designs in practice-based research literature. These designs have been commonly used to evaluate the effect of pharmacist interventions in medications management in general and specific disease states management. The lack of randomization and/or the lack of control group is a major weakness and a threat to internal validity in quasi-experimental designs ( Grady et al., 2013 ). The observed changes could be due to some effects other than the treatment.

Other Quantitative Study Designs

In addition to the common observational, experimental, and quasi-experimental designs described above, there are other designs that are used in pharmacy. These research methods include, but are not limited to, simulated client technique, discrete choice experiments, and Delphi techniques. These methods, which are considered relatively new to pharmacy, are now commonly used in pharmacy practice research. In this chapter, we briefly describe these methods and their application in pharmacy. However, a more detailed description of their components and the nitty gritty of their application in pharmacy practice are available elsewhere within this textbook.

Simulated Client Method

The use of simulated client or simulated patient (mystery shopper) method to assess practices or behaviors in pharmacy practice has received much attention in recent times ( Watson et al., 2004 , Watson et al., 2006 ). “A simulated patient is an individual who is trained to visit a pharmacy (or drug store) to enact a scenario that tests a specific behavior of the pharmacist or pharmacy staff” ( Watson et al., 2006 ). A review by Watson et al. demonstrated the versatility and applicability of this method to pharmacy practice research in both developing and developed countries ( Watson et al., 2006 ). The investigators also identified some important characteristics that should be taken into consideration in designing studies that use this technique.

This method can be used to assess wide range of cognitive pharmacy services including counseling and advice provision, treatment of minor ailments, provision of nonprescription medicines, and public health pharmacy, among other things. This method can be a robust and rigorous method of assessing pharmacy practice if used appropriately ( Watson et al., 2006 , Xu et al., 2012 ). More recent developments have documented that the simulated patient methods have been used to provide formative feedback in addition to assessing practice behavior of pharmacists and their staff ( Xu et al., 2012 ).

In a case example, a group of investigators evaluated Qatari pharmacists' prescribing, labeling, dispensing, and counseling practices in response to acute community-acquired gastroenteritis ( Ibrahim et al., 2016 ). In another example, the investigators documented the state of insomnia management at community pharmacies in Pakistan ( Hussain et al., 2013 ).

Discrete Choice Experiments

Evidence in healthcare suggests that understanding consumers' preferences can help policy-makers to design services to match their views and preferences ( Ryan, 2004 ). Traditionally, studies to understand patients' and consumers' preferences for pharmaceutical services used opinion or satisfaction survey instruments. Nevertheless, such satisfaction surveys lack the ability to identify the drivers of satisfaction or the relative importance of the different characteristics of the service ( Vass et al., 2016 ). Discrete choice experiments are a novel survey-based method in pharmacy that are predicated on economic theories that allow systematic quantification of preferences to help identify which attributes of a good or service consumers like, the relative value of each attribute, and the balance between the different attributes ( Naik Panvelkar et al., 2010 , Ryan, 2004 , Vass et al., 2016 ). In-depth description of this method and its essential elements are described in another chapter in the Encyclopedia.

Qualitative Research Designs in Pharmacy Practice

Qualitative research methodology is applied to investigate a problem that has unmeasurable variables, to get a comprehensive understanding of the topic, through discussing it with the involved individuals, and to recognize the natural context in which the investigated issue takes place ( Creswell, 2013 ). The use of qualitative research methodology is becoming increasingly common across diverse health-related disciplines, including pharmacy practice. This is because of its ability to describe social processes and behaviors associated with patients or healthcare professionals, which strengthen the research impact ( McLaughlin et al., 2016 ). Therefore, pharmacy researchers and practitioners need to be better oriented to qualitative research methods ( Behar-Horenstein et al., 2018 ).

In the following section, interpretative frameworks and philosophical orientations, methodologies, data collection and analysis methods, approaches to ensure rigor, and ethical considerations in qualitative research are briefly discussed ( Cohen et al., 2013 , Creswell, 2013 ).

Interpretative Framework and Philosophical Assumptions of Qualitative Research

Interpretative frameworks.

Interpretative frameworks are the conceptual structures for comprehension, which form researcher's reasoning and views of truth and knowledge ( Babbie, 2015 ). Different scholars have categorized qualitative research paradigms or interpretative frameworks differently. The following are examples of interpretative framework categories that are used in health science research based on the categorization of Creswell (2013) : (1) social constructivism (interpretivism) framework; (2) post-positivism framework; (3) transformative, feminist, critical frameworks and disabilities theories; (4) postmodern frameworks; (5) pragmatism frameworks.

Philosophical Assumptions

Philosophical assumptions are theories and perspectives about ontology, epistemology, axiology, and methodology, which underpin the interpretative frameworks selected by qualitative researchers ( Cohen et al., 2013 ). As with interpretative framework, there are numerous means to categorize the philosophical assumptions that are folded within interpretative framework. The following are explanations of philosophical assumptions based on the categorization of Creswell (2013) :

• 1. Ontological assumptions, which define the nature of reality
• 2. Epistemological assumptions, which clarify means for knowing reality
• 3. Axiological assumptions, which explain the role and influence of researcher values
• 4. Methodological assumptions, which identify approaches to inquiry

It is important that a qualitative researcher understands how interpretative frameworks (e.g., social constructivism, post-positivism, and pragmatic interpretative frameworks) are differentiated because of their underpinning philosophical assumptions (i.e., ontological, epistemological, axiological, and methodological assumptions).

Approaches to Inquiry (Methodology)

It is important that qualitative researchers understand the differences between the characteristics of the five qualitative approaches to inquiry, in order to select an approach to inquiry and attain methodological congruence ( Creswell, 2013 ). The five approaches to qualitative research inquiry are:

• a. Narrative research: Describes participants' written and spoken stories about their experiences with a phenomenon being investigated, while considering the chronological connection of the phenomenon's series of events ( Anderson and Kirkpatrick, 2016 , Creswell, 2013 , Czarniawska, 2004 ).
• b. Phenomenological research: Describes the essence of participants' common experiences of a phenomenon, so that the description is a general essence rather than an individual experience ( Creswell, 2013 , Giorgi, 1997 , Moustakas, 1994 ).
• c. Grounded theory research: Aims to generate a theory grounded in participants' data that conceptually explain a social phenomenon, which could involve social processes, or actions or interactions ( Creswell, 2013 , Strauss and Corbin, 1990 , Woods et al., 2016 ).
• d. Ethnographic research: Involves describing the shared patterns of values, behaviors, and beliefs of culture-sharing participants ( Creswell, 2013 , Harris, 1968 , Rosenfeld et al., 2017 ).
• e. Case study research: Provides an in-depth examination of a real-life contemporary phenomenon that researchers cannot change over time, to illustrate the significance of another general topic ( Baker, 2011 , Creswell, 2013 , de León-Castañeda et al., 2018 , Mukhalalati, 2016 , Yin, 2014 ).

Data Collection and Analysis Methods in Qualitative Research

Data collection tools in qualitative research can be categorized into the following fundamental categories ( Creswell, 2013 ):

• a. Observation
• b. Documents
• c. Individual semi-structured interviews
• d. Focus groups (FGs)
• e. Audio-visual materials
• f. Emails chat rooms, weblogs, social media, and instant messaging.
• a. Topic guides: Topic guides guide the discussions in focus groups and individual interviews, and contain open-ended questions and probes, to enable the researcher to understand the complete picture, based on participant views and experiences. They are developed based on the literature review, aim and objectives, research questions, and propositions ( Kleiber, 2004 ).
• b. Audio recording of FGs and interviews: Audio recording of discussions that take place in interviews and FGs is essential for managing and analyzing data, and for increasing the accuracy of data collection and analysis, and ultimately enhancing the dependability and credibility of the research ( Rosenthal, 2016 , Tuckett, 2005 ).
• c. Transcription of FGs and interviews recording: Verbatim transcription refers to the word-for-word conversion of oral words from an audio-recorded format into a scripted text format. Transcribing data is considered as the first data reduction step because it generates texts that can be examined and rechecked ( Miles et al., 2014 , Grossoehme, 2014 ).

Data analysis comprises several fundamental steps, including reading the transcribed text, arranging data, coding data deductively based on prefigured themes or inductively to produce emergent themes, and then summarizing the codes into themes, and finally presenting the analyzed data as results ( Cohen et al., 2013 , Crabtree and Miller, 1999 , Pope et al., 2000 ).

The most commonly used data analysis methods in health science research are:

Thematic analysis is characterized by identifying, analyzing, and reporting themes that are available in the data ( Braun and Clarke, 2006 , Castleberry and Nolen, 2018 ).

Content analysis comprises systematic coding followed by quantification of the analyzed data in a logical and unbiased way ( Berelson, 1952 , Vaismoradi et al., 2013 ).

Discourse analysis emphasizes the core format and the structure of texts to examine the assumptions and concealed aspirations behind discourses ( Brown and Yule, 1983 , Gee, 2004 ).

Quality Perspectives in Qualitative Research

Qualitative research validation involves ensuring the rigor of the utilized data collection, management, and analysis methods, by utilizing approaches to ensure the quality. In pharmacy practice research, Hadi and Closs, 2016a , Hadi and Closs, 2016b argued that quality in qualitative research topic has not been discussed widely in the literature, and therefore Hadi and Closs, 2016a , Hadi and Closs, 2016b suggested using several trustworthiness criteria to ensure the rigor of qualitative study. The trustworthiness criteria for ensuring quality in qualitative research ( Lincoln and Guba, 1985 ) are:

This criterion aims to ensure that the results are true and increases the possibility that the conclusions are credible ( Cohen and Crabtree, 2008 ).

This criterion aims to indicate that the research results are repeatable and consistent, in order to support the conclusions of the research ( Cohen and Crabtree, 2008 ).

This criterion aims to confirm the neutrality in interpretation by ensuring that the perspectives of participants, not the bias of researchers, influence the results ( Krefting, 1991 ).

This criterion involves identifying the contexts to which the study results can be generalized, and indicating if the study conclusions can be applied in similar setting ( Yin, 2014 ).

Reflexivity implies revealing and evaluating the effect and biases that researchers can possibly bring to research process, by explaining the researcher's opinion, feelings, and experience with the phenomenon in question, and explaining the influence of this experience on research methods, findings, and write-ups ( Creswell, 2013 , Krefting, 1991 , Lincoln and Guba, 1985 ).

Ethical Considerations

Obtaining an ethical approval from the Institutional Review Board (IRB) is required before conducting the qualitative research ( Creswell, 2013 ). The key ethical issues that need to be considered are:

Informed consent refers to the decision taken by a competent individual to voluntarily participate in a research, after adequately understanding the research. Participant information leaflet is usually distributed to participants before they consent to participate in the research to clarify them the voluntary nature of research participation, the aim and objectives of the research, the rights of the respondents and the potential risks and harms, the data collection, management and storage conditions, and the right of participants to withdraw from the research ( Jefford and Moore, 2008 ).

The anonymity is usually ensured by not disclosing names of participants and by utilizing a code system to identify them during data collection, management, analysis, and in the writing up of the research. The confidentiality of participants and data is ensured by using a code system to identify participants, and by storing all data in a locked cabinet and a password-protected computer for a specified period of time ( Creswell, 2013 ).

Power imbalance is caused by the fact that participants have the experience about the investigated phenomenon, and researchers need to obtain information about these experiences. The power imbalance is usually associated with interaction between the researcher and participants during recruitment stage, and during data collection, analysis, interpretation, and validation stages. Hence, researchers should take suitable measures at each stage to decrease the influence of possible power imbalance, and should enhance trust with participants ( Karnieli-Miller et al., 2009 , Yardley, 2000 ).

Mixed Methods in Pharmacy Practice Research

Research studies in pharmacy practice usually utilize single-method research designs. However, often these report numerous limitations and may not adequately answer the research question. Therefore, the combination of more than one research method to answer certain research questions has become increasingly common in pharmacy practice research ( Ryan et al., 2015 ). Mixed methods research design is now a popular and widely used research paradigm in pharmacy practice research fields ( Hadi et al., 2013 , Hadi et al., 2014 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b , Ryan et al., 2015 ). Mixed methods research allows the expansion of the scope of research to offset the weaknesses of using either quantitative or qualitative approach alone ( Creswell et al., 2004 , Hadi et al., 2013 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b , Pluye and Hong, 2014 ). Typically, qualitative and quantitative data are collected concurrently or sequentially in order to increase the validity and the comprehensiveness of the study findings ( Creswell et al., 2004 , Hadi et al., 2013 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b , Pluye and Hong, 2014 , Ryan et al., 2015 ). The mixed method approach provides an expanded understanding of phenomenon under investigation through the comparison between qualitative and quantitative data ( Hadi et al., 2013 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b , Pluye and Hong, 2014 ).

This section provides an overview and application of mixed method research in pharmacy practice. However, considerations in selecting, designing, and analyzing mixed methods research studies as well as the various typologies of mixed methods research are discussed elsewhere. Johnson et al. (2007) proposed the following definition for mixed methods research: “The type of research in which a researcher or team of researchers combines elements of qualitative and quantitative research approaches (e.g., use of qualitative and quantitative viewpoints, data collection, analysis, inference techniques) for the broad purpose of breadth and depth of understanding and corroboration.”

Mixed methods design allows the viewpoints of participants to be reflected, enables methodological flexibility, and promotes multidisciplinary teamwork ( Ryan et al., 2015 ). Furthermore, the approach allows a more holistic understanding of the research question. However, its major limitations include: need for wide range of research expertise across the research team members, highly labor-intensive, and the complexity of data integration.

Scholars believe that it is challenging to provide researchers with a step-by-step guide on how to undertake a mixed methods study and that this is driven by the specific research question ( Ryan et al., 2015 ). Nevertheless, the investigator should precisely determine the type of qualitative and quantitative methods to be employed, the order of data collection to be undertaken, the data collection instruments to be used, and the method of data analysis ( Ryan et al., 2015 ). This approach encompasses a synthesis of findings from both quantitative and qualitative components, which is achieved through integration of the findings from each approach ( Hadi et al., 2013 ; Hadi and Closs, 2016a , Hadi and Closs, 2016b , Pluye and Hong, 2014 ).

Different models or typologies for mixed methods research have been described in the literature. The most common typologies used in pharmacy practice and health services research include: concurrent or convergent parallel design, exploratory sequential design, explanatory sequential design, and the embedded design ( Hadi et al., 2013 , Pluye and Hong, 2014 ). Scholars believe that there are several factors to consider when selecting the typology or model of mixed methods research to use. These factors include: the order of qualitative and quantitative data collection (concurrent vs. sequential); priority of data (i.e., which type of data has priority between quantitative and qualitative data); purpose of integration of the data (e.g., triangulation); and number of data strands ( Hadi et al., 2013 , Pluye and Hong, 2014 ). In mixed methods research, integration of qualitative and quantitative findings is critical, and this research approach does not simply involve the collection of these data ( Ryan et al., 2015 ).

Summary and Take-Home Messages

• • In the era of evidence-based practice, it is not sufficient to propose new pharmacy services or roles without evidence of their benefit.
• • New pharmacy services and new roles must be proven to be feasible, acceptable, beneficial, and cost-effective.
• • Practice-based research provides such evidence and can inform policy, confirm the value of the new service, and change practice.
• • Various study designs, including, but not limited to experimental, quasi-experimental, observational, qualitative, and mixed-methods designs, have been used in pharmacy practice research.
• • Pharmacy practice researchers need to be competent in the selection, design, application, and interpretation of these methodological and analytical approaches.
• • The choice of any study design in pharmacy practice research is driven by the expertise of the investigator, type of research question or hypothesis, data availability, time orientation, ethical issues, and availability of funding.

There is a great demand for innovation and quality in pharmacy practice. These can be achieved partly through robust and well-designed pharmacy practice research. Pharmacy students, practitioners, educators, and policy-makers are exposed to a variety of research designs and methods. We need to have the best evidence (e.g., in policy, regulation, practice) for making decisions about the optimal research design that ensures delivering an ultimate pharmacy practice and a quality patient care.

• Anderson C., Kirkpatrick S. Narrative interviewing. Int. J. Clin. Pharm. 2016; 38 :631–634. [ PubMed ] [ Google Scholar ]
• Archibugi L., Piciucchi M., Stigliano S., Valente R., Zerboni G., Barucca V., …, Capurso G. Exclusive and combined use of statins and aspirin and the risk of pancreatic cancer: a case-control study. Sci. Rep. 2017; 7 :13024. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Awaisu A., Alsalimy N. Pharmacists' involvement in and attitudes toward pharmacy practice research: a systematic review of the literature. Res. Social Adm. Pharm. 2015; 11 :725–748. [ PubMed ] [ Google Scholar ]
• Babbie E. Nelson Education; 2015. The Practice of Social Research. [ Google Scholar ]
• Baker G.R. The contribution of case study research to knowledge of how to improve quality of care. BMJ Quality Safety. 2011; 20 :i30–i35. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Behar-Horenstein L.S., Beck D.E., Su Y. Perceptions of pharmacy faculty need for development in educational research. Curr. Pharm. Teach. Learn. 2018; 10 :34–40. [ PubMed ] [ Google Scholar ]
• Berelson, B., 1952. Content analysis in communication research.
• Bond C. The need for pharmacy practice research. Int. J. Pharm. Pract. 2006; 14 :1–2. [ Google Scholar ]
• Bousquet E., Beydoun T., Rothschild P.-R., Bergin C., Zhao M., Batista R., …, Behar-Cohen F. Spironolactone for nonresolving central serous chorioretinopathy: a Randomized Controlled Crossover Study. Retina (Philadelphia, PA) 2015; 35 (12):2505–2515. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Braun V., Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006; 3 :77–101. [ Google Scholar ]
• Brown C.A., Lilford R.J. The stepped wedge trial design: a systematic review. BMC Med. Res. Methodol. 2006; 6 :54. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Brown G., Yule G. Cambridge University Press; 1983. Discourse Analysis. [ Google Scholar ]
• Castleberry A., Nolen A. Thematic analysis of qualitative research data: is it as easy as it sounds? Curr. Pharm. Teach. Learn. 2018; 10 (6):807–815. [ PubMed ] [ Google Scholar ]
• Chen T.F., Hughes C.M. Why have a special issue on methods used in clinical pharmacy practice research? Int. J. Clin. Pharm. 2016; 38 :599–600. [ PubMed ] [ Google Scholar ]
• Chim L., Salkeld G., Kelly P., Lipworth W., Hughes D.A., Stockler M.R. Societal perspective on access to publicly subsidised medicines: a cross sectional survey of 3080 adults in Australia. PLoS ONE. 2017; 12 (3):e0172971. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Cohen D.J., Crabtree B.F. Evaluative criteria for qualitative research in health care: controversies and recommendations. Ann. Fam. Med. 2008; 6 :331–339. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Cohen L., Manion L., Morrison K. Routledge; 2013. Research Methods in Education. [ Google Scholar ]
• Colli J.L., Colli A. International comparison of prostate cancer mortality rates with dietary practices and sunlight levels. Urologic Oncol. 2006; 24 :184–194. [ PubMed ] [ Google Scholar ]
• Crabtree B.F., Miller W.L. Sage Publications; 1999. Doing Qualitative Research. [ Google Scholar ]
• Creswell J.W. Sage; 2013. Qualitative Inquiry and Research Design: Choosing Among Five Approaches. [ Google Scholar ]
• Creswell J.W., Fetters M.D., Ivankova N.V. Designing a mixed methods study in primary care. Ann. Fam. Med. 2004; 2 :7–12. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Cummings S.R., Grady D., Hulley S.B. Designing a randomized blinded trial. In: Hulley S.B., Cummings S.R., Browner W.S., Grady D., Newman T.B., editors. Designing Clinical Research. fourth ed. Wolters Kluwer Health/Lippincott Williams & Wilkins; Philadelphia: 2013. [ Google Scholar ]
• Czarniawska B. Sage; 2004. Narratives in Social Science Research. [ Google Scholar ]
• De Jong H.J.I., Kingwell E., Shirani A., Cohen Tervaert J.W., Hupperts R., Zhao Y., …, Tremlett H. Evaluating the safety of β-interferons in MS: a series of nested case-control studies. Neurology. 2017; 88 (24):2310–2320. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• de León-Castañeda C.D., Gutiérrez-Godínez J., Colado-Velázquez J., III, Toledano-Jaimes C. Healthcare professionals' perceptions related to the provision of clinical pharmacy services in the public health sector of Mexico: a case study. Res. Soc. Administr. Pharm. 2018; 15 (3):321–329. [ PubMed ] [ Google Scholar ]
• Etminan M., Samii A. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs. Pharmacotherapy. 2004; 24 :964–969. [ PubMed ] [ Google Scholar ]
• Etminan M. Pharmacoepidemiology II: the nested case-control study—a novel approach in pharmacoepidemiologic research. Pharmacotherapy. 2004; 24 :1105–1109. [ PubMed ] [ Google Scholar ]
• Gee J.P. Routledge; 2004. An Introduction to Discourse Analysis: Theory and Method. [ Google Scholar ]
• Giorgi A. The theory, practice, and evaluation of the phenomenological method as a qualitative research procedure. J. Phenomenol. Psychol. 1997; 28 :235–260. [ Google Scholar ]
• Grady D., Cummings S.R., Hulley S.B. Alternative trial designs and implementation issues. In: Hulley S.B., Cummings S.R., Browner W.S., Grady D., Newman T.B., editors. Designing Clinical Research. fourth ed. Wolters Kluwer Health/Lippincott Williams & Wilkins; Philadelphia: 2013. [ Google Scholar ]
• Green J.A., Norris P. Quantitative methods in pharmacy practice research. In: Babar Z.-U.-D., editor. Pharmacy Practice Research Methods. first ed. Springer International Publishing; Switzerland: 2015. [ Google Scholar ]
• Grossoehme D.H. Overview of qualitative research. J. Health Care Chaplaincy. 2014; 20 :109–122. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Hadi M.A., Closs S.J. Applications of mixed-methods methodology in clinical pharmacy research. Int. J. Clin. Pharm. 2016; 38 :635–640. [ PubMed ] [ Google Scholar ]
• Hadi M.A., Closs S.J. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int. J. Clin. Pharm. 2016; 38 :641–646. [ PubMed ] [ Google Scholar ]
• Hadi M.A., Alldred D.P., Closs S.J., Briggs M. Mixed-methods research in pharmacy practice: basics and beyond (part 1) Int. J. Pharm. Pract. 2013; 21 :341–345. [ PubMed ] [ Google Scholar ]
• Hadi M.A., Alldred D.P., Closs S.J., Briggs M. Mixed-methods research in pharmacy practice: recommendations for quality reporting (part 2) Int. J. Pharm. Pract. 2014; 22 :96–100. [ PubMed ] [ Google Scholar ]
• Harris A.D., Mcgregor J.C., Perencevich E.N., Furuno J.P., Zhu J., Peterson D.E., Finkelstein J. The use and interpretation of quasi-experimental studies in medical informatics. J. Am. Med. Inform. Assoc. 2006; 13 :16–23. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Harris M. Routledge and Kegan Paul; London: 1968. Emics, Etics, and the New Ethnography. The Rise of Anthropological Theory: a History of Theories of Culture. pp. 568–604. [ Google Scholar ]
• Hulley S.B., Cummings S.R., Newman T.B. Designing cross-sectional and cohort studies. In: Hulley S.B., Cummings S.R., Browner W.S., Grady D., Newman T.B., editors. Designing Clinical Research. fourth ed. Wolters Kluwer Health/Lippincott Williams & Wilkins; Philadelphia: 2013. [ Google Scholar ]
• Hussain A., Ibrahim M.I., Malik M. Assessment of disease management of insomnia at community pharmacies through simulated visits in Pakistan. Pharm. Pract. 2013; 11 (4):179–184. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Ibrahim M.I., Palaian S., Al-Sulaiti F., El-Shami S. Evaluating community pharmacy practice in Qatar using simulated patient method: acute gastroenteritis management. Pharm. Pract. 2016; 14 (4):800. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Jefford M., Moore R. Improvement of informed consent and the quality of consent documents. Lancet Oncol. 2008; 9 :485–493. [ PubMed ] [ Google Scholar ]
• Johnson R.B., Onwuegbuzie A.J., Turner L.A. Toward a definition of mixed methods research. J. Mixed Methods Res. 2007; 1 :112–133. [ Google Scholar ]
• Kaae S., Traulsen J.M. Qualitative methods in pharmacy practice research. In: Babar Z.-U.-D., editor. Pharmacy Practice Research Methods. first ed. Springer International Publishing; Switzerland: 2015. [ Google Scholar ]
• Karnieli-Miller O., Strier R., Pessach L. Power relations in qualitative research. Qual. Health Res. 2009; 19 :279–289. [ PubMed ] [ Google Scholar ]
• Kernan W.N., Viscoli C.M., Brass L.M., Broderick J.P., Brott T., Feldmann E., Morgenstern L.B., Wilterdink J.L., Horwitz R.I. Phenylpropanolamine and the risk of hemorrhagic stroke. N. Engl. J. Med. 2000; 343 :1826–1832. [ PubMed ] [ Google Scholar ]
• Kleiber P.B. Focus groups: More than a method of qualitative inquiry. Foundations Res. 2004:87–102. [ Google Scholar ]
• Koshman S.L., Blais J. What is pharmacy research? Can. J. Hosp. Pharm. 2011; 64 :154–155. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Krass I. Quasi experimental designs in pharmacist intervention research. Int. J. Clin. Pharm. 2016; 38 :647–654. [ PubMed ] [ Google Scholar ]
• Krefting L. Rigor in qualitative research: the assessment of trustworthiness. Am. J. Occup. Ther. 1991; 45 :214–222. [ PubMed ] [ Google Scholar ]
• Lin C.-W., Wen Y.-W., Chen L.-K., Hsiao F.-Y. Potentially high-risk medication categories and unplanned hospitalizations: a case–time–control study. Sci. Rep. 2017; 7 :41035. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Lincoln Y.S., Guba E.G. Sage; 1985. Naturalistic Inquiry. [ Google Scholar ]
• Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 1991; 133 :144–153. [ PubMed ] [ Google Scholar ]
• McLaughlin J.E., Bush A.A., Zeeman J.M. Mixed methods: expanding research methodologies in pharmacy education. Curr. Pharm. Teach. Learn. 2016; 8 :715–721. [ Google Scholar ]
• Miles M.B., Huberman A.M., Saldana J. Sage Publications; CA, USA: 2014. Qualitative Data Analysis: A Method Sourcebook. [ Google Scholar ]
• Moustakas C. Sage; 1994. Phenomenological Research Methods. [ Google Scholar ]
• Mukhalalati, B., 2016. Examining the disconnect between learning theories and educational practices in the PharmD programme at Qatar University: a case study.
• Murphy A.L., Gardner D.M., Kisely S., Cooke C., Kutcher S.P., Hughes J. A qualitative study of antipsychotic medication experiences of youth. J. Can. Acad. Child Adolesc. Psychiatry. 2015; 24 :61. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Naik Panvelkar P., Armour C., Saini B. Community pharmacy-based asthma service-what do patients prefer? J. Asthma. 2010; 47 :1085–1093. [ PubMed ] [ Google Scholar ]
• Newman T.B., Browner W.S., Cummings S.R., Hulley S.B. Designing case-control studies. In: Hulley S.B., Cummings S.R., Browner W.S., Grady D., Newman T.B., editors. Designing Clinical Research. fourth ed. Wolters Kluwer Health/Lippincott Williams & Wilkins; Philadelphia: 2013. [ Google Scholar ]
• Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N. Engl. J. Med. 2007; 357 (14):1373–1381. [ PubMed ] [ Google Scholar ]
• Odili A.N., Ezeala-Adikaibe B., Ndiaye M.B., Anisiuba B.C., Kamdem M.M., Ijoma C.K., …, Ulasi I.I. Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients. Trials. 2012; 13 :59. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Pluye P., Hong Q.N. Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annu. Rev. Public Health. 2014; 35 :29–45. [ PubMed ] [ Google Scholar ]
• Pope C., Ziebland S., Mays N. Qualitative research in health care: analysing qualitative data. Br. Med. J. 2000; 320 :114. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Prashanth N.S., Elias M.A., Pati M.K., Aivalli P., Munegowda C.M., Bhanuprakash S., …, Devadasan N. Improving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design. BMC Health Services Res. 2016; 16 (1):421. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Rosenfeld E., Kinney S., Weiner C., Newall F., Williams A., Cranswick N., Wong I., Borrott N., Manias E. Interdisciplinary medication decision making by pharmacists in pediatric hospital settings: an ethnographic study. Res. Social Adm. Pharm. 2018; 14 :269–278. [ PubMed ] [ Google Scholar ]
• Rosenthal M. Qualitative research methods: why, when, and how to conduct interviews and focus groups in pharmacy research. Curr. Pharm. Teach. Learn. 2016; 8 :509–516. [ Google Scholar ]
• Ryan C.A., Cadogan C., Hughes C. Mixed methods research in pharmacy practice. In: Babar Z.U.D., editor. Pharmacy Practice Research Methods. first ed. Springer International Publishing; Switzerland: 2015. [ Google Scholar ]
• Ryan M. Discrete choice experiments in health care. BMJ. 2004; 328 :360–361. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Setia M.S. Methodology series module 1: Cohort studies. Indian J. Dermatol. 2016; 61 :21–25. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Setia M.S. Methodology series module 3: Cross-sectional studies. Indian J. Dermatol. 2016; 61 :261–264. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Shiyanbola O.O., Mort J.R. Patients' perceived value of pharmacy quality measures: a mixed-methods study. BMJ Open. 2015; 5 (1):e006086. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Strauss A., Corbin J.M. Sage Publications, Inc.; CA, USA: 1990. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. [ Google Scholar ]
• Tashakkori A., Creswell J.W. Editorial: The new era of mixed methods. J. Mixed Methods Res. 2007; 1 :3–7. [ Google Scholar ]
• Teo K.K., Ounpuu S., Hawken S., Pandey M., Valentin V., Hunt D. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006; 368 (9536):647–658. [ PubMed ] [ Google Scholar ]
• Tubiana S., Blotière P.-O., Hoen B., Lesclous P., Millot S., Rudant J., …, Duval X. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case-crossover study. BMJ. 2017; 358 :j3776. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Tuckett A.G. Part II. Rigour in qualitative research: complexities and solutions: Anthony G Tuckett outlines the strategies and operational techniques he used to attain rigour in a qualitative research study through relying on Guba and Lincoln's trustworthiness criterion. Research strategies such as use of personal journals, audio recording and transcript auditing, and operational techniques including triangulation strategies and peer review, are examined. Nurse Researcher. 2005; 13 :29–42. [ PubMed ] [ Google Scholar ]
• Vaismoradi M., Turunen H., Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs. Health Sci. 2013; 15 :398–405. [ PubMed ] [ Google Scholar ]
• Vass C., Gray E., Payne K. Discrete choice experiments of pharmacy services: a systematic review. Int. J. Clin. Pharm. 2016; 38 :620–630. [ PubMed ] [ Google Scholar ]
• Watson M.C., Skelton J.R., Bond C.M., Croft P., Wiskin C.M., Grimshaw J.M., Mollison J. Simulated patients in the community pharmacy setting – Using simulated patients to measure practice in the community pharmacy setting. Pharm. World Sci. 2004; 26 :32–37. [ PubMed ] [ Google Scholar ]
• Watson M., Norris P., Granas A. A systematic review of the use of simulated patients and pharmacy practice research. Int. J. Pharm. Pract. 2006; 14 :83–93. [ PubMed ] [ Google Scholar ]
• Wei L., Ratnayake L., Phillips G., Mcguigan C.C., Morant S.V., Flynn R.W., …, Macdonald T.M. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study. Br. J. Clin. Pharmacol. 2017; 83 (6):1298–1308. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Woods A., Cashin A., Stockhausen L. Communities of practice and the construction of the professional identities of nurse educators: a review of the literature. Nurse Educ. Today. 2016; 37 :164–169. [ PubMed ] [ Google Scholar ]
• Wu E.B., Sung J.J.Y. Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS. Lancet. 2003; 361 (9368):1520–1521. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Xu T., De Almeida Neto A.C., Moles R.J. A systematic review of simulated-patient methods used in community pharmacy to assess the provision of non-prescription medicines. Int. J. Pharm. Pract. 2012; 20 :307–319. [ PubMed ] [ Google Scholar ]
• Yardley L. Dilemmas in qualitative health research. Psychol. Health. 2000; 15 :215–228. [ Google Scholar ]
• Yin R.K. Sage Publications; 2014. Case Study Research: Design and Methods. [ Google Scholar ]

Further Reading

• Baxter P., Jack S. Qualitative case study methodology: study design and implementation for novice researchers. Qual. Rep. 2008; 13 :544–559. [ Google Scholar ]
• Boyatzis R.E. Sage; 1998. Transforming Qualitative Information: Thematic Analysis and Code Development. [ Google Scholar ]
• Bryman A. Oxford University Press; 2015. Social Research Methods. [ Google Scholar ]
• Easton K.L., Mccomish J.F., Greenberg R. Avoiding common pitfalls in qualitative data collection and transcription. Qual. Health Res. 2000; 10 :703–707. [ PubMed ] [ Google Scholar ]
• Eisner E.W. Teachers College Press; 2017. The Enlightened Eye: Qualitative Inquiry and the Enhancement of Educational Practice. [ Google Scholar ]
• Gibbs A. Thousand Oaks; 2012. Focus groups and group interviews. Research Methods and Methodologies in Education. pp. 186–192. [ Google Scholar ]
• Grodstein F., Manson J.E., Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. Ann. Intern. Med. 2001; 135 :1–8. [ PubMed ] [ Google Scholar ]
• Halcomb E.J., Davidson P.M. Is verbatim transcription of interview data always necessary? Appl. Nurs. Res. 2006; 19 :38–42. [ PubMed ] [ Google Scholar ]
• Hanson J.L., Balmer D.F., Giardino A.P. Qualitative research methods for medical educators. Acad. Pediatr. 2011; 11 :375–386. [ PubMed ] [ Google Scholar ]
• Jonsson P., Jakobsson A., Hensing G., Linde M., Moore C.D., Hedenrud T. Holding on to the indispensable medication—a grounded theory on medication use from the perspective of persons with medication overuse headache. J. Headache Pain. 2013; 14 (1):43. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Kruijtbosch M., Göttgens-Jansen W., Floor-Schreudering A., Van Leeuwen E., Bouvy M.L. Moral dilemmas of community pharmacists: a narrative study. Int. J. Clin. Pharm. 2018; 40 :74–83. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Landier W., Hughes C.B., Calvillo E.R., Anderson N.L.R., Briseño-Toomey D., Dominguez L., Martinez A.M., Hanby C., Bhatia S. A grounded theory of the process of adherence to oral chemotherapy in Hispanic and Caucasian children and adolescents with acute lymphoblastic leukemia. J. Pediatr. Oncol. Nurs. 2011; 28 :203–223. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Lecompte M.D., Goetz J.P. Problems of reliability and validity in ethnographic research. Rev. Educ. Res. 1982; 52 :31–60. [ Google Scholar ]
• Maclean L.M., Meyer M., Estable A. Improving accuracy of transcripts in qualitative research. Qual. Health Res. 2004; 14 :113–123. [ PubMed ] [ Google Scholar ]
• Morgan D.L. Sage; 1997. Focus Groups as Qualitative Research. [ Google Scholar ]
• Morse J.M. Sage Publications Sage CA; Thousand Oaks, CA: 1998. The Contracted Relationship: Ensuring Protection of Anonymity and Confidentiality. [ PubMed ] [ Google Scholar ]
• Myers G. Cambridge University Press; 2004. Matters of Opinion: Talking about Public Issues. [ Google Scholar ]
• Nisbet, J., Watt, J., 1984. Case Study, Chapter 5 in Bell, K., et al. Conducting Small-Scale Investigations in Educational Management.
• Nunkoosing K. The problems with interviews. Qual. Health Res. 2005; 15 :698–706. [ PubMed ] [ Google Scholar ]
• Pearce R. University of Birmingham; 2014. Learning How to Lead through Engagement with Enquiry Based Learning as a Threshold Process: A Study of How Post-graduate Certificate in Education Healthcare Professional Students Learn to Lead. [ Google Scholar ]
• Ping W.L. Data analysis in health-related qualitative research. Singapore Med. J. 2008; 49 :435–1435. [ PubMed ] [ Google Scholar ]
• Polit D.F., Beck C.T. Lippincott Williams & Wilkins; 2013. Essentials of Nursing Research: Appraising Evidence for Nursing Practice. [ Google Scholar ]
• Rivas C., Sohanpal R., Macneill V., Steed L., Edwards E., Antao L., …, Walton R. Determining counselling communication strategies associated with successful quits in the National Health Service community pharmacy Stop Smoking programme in East London: a focused ethnography using recorded consultations. BMJ Open. 2017; 7 (10):e015664. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Rubin H.J., Rubin I.S. Sage; 2012. Qualitative Interviewing: The Art of Hearing Data. [ Google Scholar ]
• Ryan K., Patel N., Lau W.M., Abu-Elmagd H., Stretch G., Pinney H. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation. BMC Health Serv. Res. 2018; 18 :234. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Santiago-Delefosse M., Gavin A., Bruchez C., Roux P., Stephen S.L. Quality of qualitative research in the health sciences: analysis of the common criteria present in 58 assessment guidelines by expert users. Soc. Sci. Med. 2016; 148 :142–151. [ PubMed ] [ Google Scholar ]
• Shiyanbola O.O., Brown C.M., Ward E.C. “I did not want to take that medicine”: African-Americans' reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence. Patient Prefer. Adherence. 2018; 12 :409. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Shoemaker S.J., Ramalho D.E., Oliveira D. Understanding the meaning of medications for patients: the medication experience. Pharm. World Sci. 2008; 30 (1):86–91. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Silverman D. SAGE Publications Limited; 2013. Doing Qualitative Research: A Practical Handbook. [ Google Scholar ]
• Sim J. Informed consent: ethical implications for physiotherapy. Physiotherapy. 1986; 72 :584–587. [ Google Scholar ]
• Skukauskaite, A., 2012. Transparency in Transcribing: Making Visible Theoretical Bases Impacting Knowledge Construction from Open-Ended Interview Records.
• Sofaer S. Qualitative methods: what are they and why use them? Health Serv. Res. 1999; 34 :1101. [ PMC free article ] [ PubMed ] [ Google Scholar ]
• Tobin G.A., Begley C.M. Methodological rigour within a qualitative framework. J. Adv. Nurs. 2004; 48 :388–396. [ PubMed ] [ Google Scholar ]
• Todd A., Holmes H., Pearson S., Hughes C., Andrew I., Baker L., Husband A. I don't think I'd be frightened if the statins went': a phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals. BMC Palliat Care. 2016; 15 :13. [ PMC free article ] [ PubMed ] [ Google Scholar ]

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to  upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

• We're Hiring!
• Help Center

PHARMACY MANAGEMENT SYSTEM OF PUBLIC SECTOR 2016 PHARMACY MANAGEMENT SYSTEM OF PUBLIC SECTOR PHARMACY MANAGEMENT SYSTEM OF PUBLIC SECTOR 2016

Pharmacy management system that is designed to enhance the security and management system to improve the accuracy and efficiency in pharmaceutical stores. It is a computer-based inventory management system, the cost; the pharmacist helps to improve medical safety, etc.

Related Papers

theophilus abba

Research Proposal

IJIREM JOURNAL

This research is based on the order for consumers to make effective decisions when using drugs, there is the need to make certain information available. The use of drug verification system to provide information on registered pharmaceutical drugs will be of immense help to the country and the world. With the help of this system, the user can search if a prescribed drug is registered. This system is a web-based application developed using Hypertext Pre-processor (PHP) and MYSQL database, the methodology used in the implementation of the system is V-shaped model of System Development Life Cycle (SDLC). This system integrates with registered drugs and their respective details from National Agency for Food and Drug Administration and Control (NAFDAC) and the software developed for the implementation of this research can be used by any drug enforcement agency other than NAFDAC. It also provides solution to help in the fight against counterfeit drugs and majorly unregistered drugs by allowing users to verify the authenticity of the drugs and to report otherwise.

Vasco Almeida

We propose the design of a digital service ecosystem for the pharmaceutical compounds supply chain. Our method of inquiry is the canonical action research and a retail pharmacy provides the setting. A comprehensive review of existing literature about compounding of medicines is provided and six digital services identified: Supply management, Product traceability, Quality management, Order management, Digital assistant, and Product experience. The new services are supported by dynamic QR code identification and mHealth technologies. Preliminary results suggest that the digital ecosystems offer an opportunity to implement electronic labels (e-labels) in pharmacies, improve medicine information quality, and restore a broken link between medicine customer and medicine producer. Our findings can assist service design and service innovation in pharmaceutical supply chains. Moreover, they can support retail pharmacies in dealing with the increase of medicine compounding, address regulatory pressure for e-labeling, and to take advantage of their proximity to local communities.

Ijaems Journal

— Health institution requires quality data and information management to function effectively and efficiently. It is an understatement to say that many organizations, institutions or government agencies have become critically dependent on the use of database system for their successes especially in the hospital. This work aims at developing an improved hospital information management system using a function-based approach. An efficient HIMS that can be used to manage patient information and its administration is presented in this work. This is with the goal of eradicating the problem of improper data keeping, inaccurate reports, wastage of time in storing, processing and retrieving information faced by the existing hospital information system in order to improve the overall efficiency of the health institution. The system was developed with Hypertext Markup Language (HTML), Cascading Style Sheets (CSS), Hypertext Preprocessor (PHP), and My Structured Query Language (MySQL). The new system was tested using data collected from Renewal Clinic, Ibadan, Nigeria was used as case study were the data for the research was collected and the system was tested. The system provides a vital platform of information storage and retrieval in hospitals.

Muhammad Abdul Hadi

Keywords: Adverse Drug Reactions, Pharmacist, Pharmacovigilance, Malaysia reporting rate is mainly due to reporting by pharmacists working in the public sector. Adverse drug reaction reports generated by pharmacists increased from 726 (28.5%) in 2006 to 3357 (57.4%) in 200911. On the other hand, the contribution by physicians towards ADR reporting was 22.9% in 200911. The increase in the number of reports submitted by pharmacists could be a reflection of the increase in pharmacists working in public hospitals.

Eric Mbonyi

Pharmaceutical practices have evolved over time to become fully encompassed in all aspects of pharmacy itself. Such practices include: dispensing of drugs, consultation, drug regulation, and the sale of these drugs. The community pharmacies and hospital pharmacies have key roles to play in the pharmaceutical practices. For the community pharmacies in Sub-Saharan Africa, a strict approach to the sale and dispensation of drugs is not normally the case, due to the fact that laws governing pharmaceutical practices have not been fully enforced. On the part of the hospital pharmacies, there is a more controlled approach to the dispensing of drugs, as the prescriptions are readily available from the in-house doctors. There is a need for these practices to be fully enforced, and a management system introduced to the fray. With software such as the Online Pharmaceutical Management System, which provides a platform has been provided to help with drug regulation, as well as providing ease to all parties involved. The methodology used in the implementation of the software is the Incremental Model of System Development Life Cycle, which allows room for scalability as time goes on. Creating an Online Pharmaceutical Management System would help in pharmaceutical practices for all parties involved. It is eminent that the system provides a safe, secure and verified platform for all parties which help to bridge the communication gap and provide legitimate drugs. Therefore, if all recommendations are strictly adhered to, there will be strict monitoring and regulation of how drugs are circulated and a decrease in the spread of fake drugs.

T. Fulda , Alan Lyles

BACKGROUND: The Omnibus Budget Reconciliation Act of 1990 offered the promise that prospective drug utilization review (pDUR) systems would improve the quality of drug prescribing and patient drug use. There is little evidence that this promise has been fulfilled. To the contrary, there is growing evidence that suboptimal use of drugs (in terms of preventable drug-related morbidity) is at least

Journal of Computer Science IJCSIS

Mobile technologies are fast developing and it has completely changed the way we interact and provide healthcare services. The rapid spread of mobile technologies and inventive applications to address health related problems has evolved into a new field known as mobile-Health. The purpose of this research is to improve the quality and access to health care services with the aid of mobile-Health application software known as “Crescent Mobile Health”. This paper will address the problem of self medication by creating a channel of communication between a patient and doctor at distant environment there by solving emergency situations. The method used to address this problem is by designing and developing mobile-Health application software, which can be used by patients via an android smartphone that is used to communicate with a doctor/pharmacist/laboratory scientist using electronic-Health application software known as Crescent Health Information System on a desktop via the intranet. The two applications on smartphone and desktop are able to communicate via instant messaging by a persistent connection known as “sockets” and “pusher” which provides implementation for interconnectivity. The Crescent Health Information System can carry out major functionalities such as drugs and tests inventory, instant messaging, prescriptions of drugs, prescription of tests and profile update. The Crescent Mobile Health can also carry out functionalities such as instant messaging, viewing of prescribed drugs, tests, health tips and help file. The mobile-Health application software was developed using java programming language and android development studio while the electronic-Health (E-Health) application software was developed using PHP programming language and MYSQL database. The results of the development of this project concludes that mobile-Health application software has been able to resolve the problem of communication between a patient and a doctor and has provided a means to verify drugs available and tests carried out in the clinic/health sector. https://sites.google.com/site/ijcsis/

International Journal of …

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

RELATED PAPERS

American Journal of Pharmaceutical Education

Nancy Deguire

Journal of Manufacturing …

Abdul Roudsari

Filipa A Costa

Filipa A Costa , Ana Isabel Fernandes

Syed Masud Ahmed

Inês Miranda , Filipa A Costa , Ana Isabel Fernandes

Dr Paul Barach

William Pick

sruthi prithviraj

International Journal of Pharmacy

Nina Sautenkova , Kristina Mladenovska

Myrrhe Koorndijk

Sean Lyons , Paul Gorecki

Tarek Ghanem

Johan Sebastian Afanador Rodriguez

Peter Campion

Chazile Mavuso

Anusha Andy

Dimitra Petrakaki

Noel Carroll

Carole Parsons

Mark Kenneth Precilla

Harold de Asis

Sanaa Awada

Sanah Hasan

Donatela Gruda

British Journal of General Practice

zoe philips

European Scientific Journal ESJ

Steven Watson , C. Bond

Nurfajriani Nurfajriani

Akshaya S Bhagavathula

Dr Piotr Merks

Syed Nasirin

Deepak Kumar Bandari

RELATED TOPICS

•   We're Hiring!
•   Help Center
• Find new research papers in:
• Health Sciences
• Earth Sciences
• Cognitive Science
• Mathematics
• Computer Science
• Academia ©2024

• University of Michigan Library
• Research Guides

Pharmacy and Pharmacology

• Literature Reviews
• Drug Information
• Point of Care Resources
• Finding & Using Data & Statistics
• Patient Safety
• Citation Management (EndNote, Mendeley, Zotero) This link opens in a new window
• Mobile Resources
• Creating a Well-Focused Question
• Searching PubMed
• PubMed - Article Abstract Page
• Searching Other Databases - Embase
• Searching Other Databases - International Pharmaceutical Abstracts
• Academic/Professional Integrity at UM
• Research Data Management This link opens in a new window
• NIH Public Access Policy
• Research Funding & Grants This link opens in a new window

Writing literature reviews - an article from Nature

Tips from 8 authors.

• How to Write a Superb Literature Review

What is a Literature Review?

A literature review surveys scholarly articles, books, dissertations, conference proceedings & other resources that are relevant to a particular issue, area of research, or theory & provides context for a dissertation by identifying past researchon a topic.

Research tells a story, & the existing literature helps us identify where we are in the story currently. It is up to those working on a research project to continue that story with new research and new perspectives, but they must first be familiar with the story before they can move forward. 

Purpose of a Literature Review

A literature review:

• Helps you to discover the research that has been conducted on a topic already & identifies gaps in current knowledge
• Increases the breadth of your knowledge in your area of research
• Helps you identify seminal works in your area
• Allows you to provide the intellectual context for your work & position your research with other, related research
• Provides you with opposing viewpoints
• Helps you to discover research methods that may be applicable to your work

Greenfield, T. (2002). Research methods for postgraduates. 2nd ed. London: Arnold.

While there are many specific types of literature reviews, you will be writing a critical literature review to demonstrate your knowledge of a specific area & that your project is viable. 

To read more about the different types of reviews, read this article, which provides a good overview:  Maria J. Grant & Andrew Booth. "A typology of reviews: an analysis of 14 review types and associated methodologies". Health Information and Libraries Journal (26):91–108.  DOI: 10.1111/j.1471-1842.2009.00848.x

The Process of Writing a Literature Review

Frequently asked questions.

What kinds of literature are appropriate for my research question?    This will depend on your area of research, but in the health sciences, you will most often rely on scholarly journal articles, patents, conference proceedings, & data sets.

How much literature should I use?    There is no standard answer to this question, but make sure that you have enough literature to tell your story. Discuss this question with your advisor & peers.

How will I find all appropriate information to inform my research?    You should consult multiple databases & resources appropriate for your research area so that you can have a comprehensive view of the research that has already been done in your area. Browse the Pharmacy research guide for databases & other recommended resources.  Also consult with your informationist at the Taubman Health Sciences Library to determine the resources you should investigate.

How will I evaluate the literature to include trustworthy information and eliminate unnecessary or untrustworthy information?    Start with scholarly sources, such as peer-reviewed journal articles & books. Always pay attention to creditability of the source(s) & the author(s) you cite. Citation analysis (see research guides  http://guides.lib.umich.edu/citeanalysis &  http://guides.lib.umich.edu/citation ) can be useful to check the creditability of sources & authors.

How should I organize my literature? What citation management program is best for me?    Citation management software, such as Mendeley, a free citation management program, helps you collect & organize references & easily insert citations & format citations & bibliographies in thousands of styles in your Word document.

To choose the program that's right for you, consider which one works best with your literature search & writing process. This guide compares different types of citation management software & provides tutorials for each type. You may also ask your library informationist for advice.

How do I ensure academic integrity (i.e., avoid plagiarism)?    Familiarize yourself with different types of intentional and unintentional plagiarism and learn about the University's standards for academic integrity here.  Remember, citation management tools can help you avoid unintentional plagiarism by making it easy to collect & cite sources.

What Kind of Literature Should You Choose?

Different types of information sources may be critical for particular disciplines.  Please contact your library informationist for additional guidance on information sources appropriate to your research.  In addition to books, reference resources, journal articles, & datasets, these sources may be helpful.

Government documents

The U.S. Government Printing Office produces a great deal of information that is useful to researchers. Congress, the Supreme Court, the Office of the President & federal agencies are rich sources of policy information, legislation, & historical records. The University of Michigan's Clark Library is a federal depository library. Librarians there can help you find documents and records created by the federal government, as well as state & local laws & legislation.  International government information can be found in United Nations documents , available in print & online since 1946.  Also check the Grey Literature guide for more resources.

Statistics reported by government or private sources can be useful, but can also be difficult to find.  Use the Health Statistics research guide for more information on how to search & for sources.

Grey Literature

Theses & Dissertations :    Dissertations on topics similar to yours may contain information & technical details not published in other forms. You may also be inspired by how others approach similar topics.  

Conference proceedings :    For many fields, researchers present their most up-to-date research results at professional conferences. These results will later be published in conference proceedings, abstracts, or preprints. 

Other unpublished information :    For all of the above and resources, including clinical & pharmaceutical research, FDA reports, & more, visit the Grey Literature research guide .

Related Research Guides

• Grey Literature Resources & strategies for searching for information not contained in databases.
• Finding Tests & Measurement Instruments Resources, tips, & tricks for finding tests & measurement instruments in the health & social sciences.
• Bioinformatics Resources on the interdisciplinary science that uses information technology to solve molecular biology problems.
• Research Impact Assessment (Health Sciences) Explore methods and tools for assessing your research impact, including citation tracking and altmetrics.

Writing Help

• Graduate Students - Sweetland Center for Writing One-on-one assistance & workshops, all free.
• Graduate Student Writing Clinic

Information

• Author Services

Initiatives

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .

Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.

Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.

Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.

Original Submission Date Received: .

• Active Journals
• Find a Journal
• Proceedings Series
• For Authors
• For Reviewers
• For Editors
• For Librarians
• For Publishers
• For Societies
• For Conference Organizers
• Open Access Policy
• Institutional Open Access Program
• Special Issues Guidelines
• Editorial Process
• Research and Publication Ethics
• Article Processing Charges
• Testimonials
• Preprints.org
• SciProfiles
• Encyclopedia

Article Menu

• Subscribe SciFeed
• Recommended Articles
• Google Scholar
• on Google Scholar
• Table of Contents

Find support for a specific problem in the support section of our website.

Please let us know what you think of our products and services.

Visit our dedicated information section to learn more about MDPI.

JSmol Viewer

Drug delivery systems for glaucoma: a narrative review.

Graphical Abstract

1. Introduction

2. punctal plugs delivery system, 3. conjunctival fornix delivery system, 4. contact lens for ophthalmic drug delivery, 5. periocular drug delivery systems, 6. intracameral delivery system, 7. conclusions, author contributions, conflicts of interest.

• Allison, K.; Patel, D.; Alabi, O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020 , 12 , e11686. [ Google Scholar ] [ CrossRef ]
• Schuster, A.K.; Erb, C.; Hoffmann, E.M.; Dietlein, T.; Pfeiffer, N. The Diagnosis and Treatment of Glaucoma. Dtsch. Ärzteblatt Int. 2020 , 117 , 225. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Weinreb, R.N.; Aung, T.; Medeiros, F.A. The Pathophysiology and Treatment of Glaucoma: A Review. JAMA 2014 , 311 , 1901. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Newman-Casey, P.A.; Robin, A.L.; Blachley, T.; Farris, K.; Heisler, M.; Resnicow, K.; Lee, P.P. The Most Common Barriers to Glaucoma Medication Adherence. Ophthalmology 2015 , 122 , 1308–1316. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Olthoff, C.; Schouten, J.; Vandeborne, B.; Webers, C. Noncompliance with Ocular Hypotensive Treatment in Patients with Glaucoma or Ocular HypertensionAn Evidence-Based Review. Ophthalmology 2005 , 112 , 953–961.E7. [ Google Scholar ] [ CrossRef ]
• Rossi, G.C.; Pasinetti, G.M.; Scudeller, L.; Radaelli, R.; Bianchi, P.E. Do adherence rates and glaucomatous visual field progression correlate? Eur. J. Ophthalmol. 2011 , 21 , 410–414. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Kompella, U.B.; Hartman, R.R.; Patil, M.A. Extraocular, periocular and intraocular routes for sustained drug delivery for glaucoma. Prog. Retin. Eye Res. 2021 , 82 , 100901. [ Google Scholar ] [ CrossRef ] [ PubMed ] [ PubMed Central ]
• Singh, R.B.; Ichhpujani, P.; Thakur, S.; Jindal, S. Promising Therapeutic Drug Delivery Systems for Glaucoma: A Comprehensive Review. Ophthalmol. Eye Dis. 2020 , 12 , 251584142090574. [ Google Scholar ] [ CrossRef ]
• Kesav, N.P.; Young, C.E.C.; Ertel, M.K.; Seibold, L.K.; Kahook, M.Y. Sustained-Release Drug Delivery Systems for the Treatment of Glaucoma. Int. J. Ophthalmol. 2021 , 14 , 148–159. [ Google Scholar ] [ CrossRef ]
• Jehangir, N.; Bever, G.; Mahmood, S.M.J.; Moshirfar, M. Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease. J. Ophthalmol. 2016 , 2016 , 9312340. [ Google Scholar ] [ CrossRef ]
• Chen, X.; Shen, T. Advances in Innovative Delivery Systems for Antiglaucoma Drugs. Curr. Opin. Ophthalmol. 2023 , 34 , 123–128. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Calonge, M. The Treatment of Dry Eye. Surv. Ophthalmol. 2001 , 45 (Suppl. S2), S227–S239. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Balaram, M.; Schaumberg, D.A.; Dana, M.R. Efficacy and Tolerability Outcomes after Punctal Occlusion with Silicone Plugs in Dry Eye Syndrome. Am. J. Ophthalmol. 2001 , 131 , 30–36. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Chen, M.; Yung Choi, S. Preliminary Outcomes of Temporary Collagen Punctal Plugs for Patients with Dry Eye and Glaucoma. Med. Hypothesis Discov. Innov. Ophthalmol. 2020 , 9 , 56–60. [ Google Scholar ]
• Sherwin, J.C.; Ratnarajan, G.; Elahi, B.; Bilkiewicz-Pawelec, A.; Salmon, J.F. Effect of a Punctal Plug on Ocular Surface Disease in Patients Using Topical Prostaglandin Analogues: A Randomized Controlled Trial. Clin. Exp. Ophthalmol. 2018 , 46 , 888–894. [ Google Scholar ] [ CrossRef ]
• Perera, S.A.; Ting, D.S.; Nongpiur, M.E.; Chew, P.T.; Aquino, M.C.D.; Sng, C.C.; Ho, S.-W.; Aung, T. Feasibility Study of Sustained-Release Travoprost Punctum Plug for Intraocular Pressure Reduction in an Asian Population. Clin. Ophthalmol. 2016 , 10 , 757–764. [ Google Scholar ] [ CrossRef ]
• Kompella, U.B.; Kadam, R.S.; Lee, V.H.L. Recent Advances in Ophthalmic Drug Delivery. Ther. Deliv. 2010 , 1 , 435–456. [ Google Scholar ] [ CrossRef ]
• Zimmerman, T.J.; Kooner, K.S.; Kandarakis, A.S.; Ziegler, L.P. Improving the Therapeutic Index of Topically Applied Ocular Drugs. Arch. Ophthalmol. 1984 , 102 , 551–553. [ Google Scholar ] [ CrossRef ]
• Huang, T.C.; Lee, D.A. Punctal Occlusion and Topical Medications for Glaucoma. Am. J. Ophthalmol. 1989 , 107 , 151–155. [ Google Scholar ] [ CrossRef ]
• Tyson, S.L.; Bafna, S.; Gira, J.P.; Goldberg, D.F.; Jones, J.J.; Jones, M.P.; Kim, J.K.; Martel, J.M.; Nordlund, M.L.; Piovanetti-Perez, I.K.; et al. Multicenter Randomized Phase 3 Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation and Pain after Cataract Surgery. J. Cataract. Refract. Surg. 2019 , 45 , 204–212. [ Google Scholar ] [ CrossRef ]
• Gira, J.P.; Sampson, R.; Silverstein, S.M.; Walters, T.R.; Metzinger, J.L.; Talamo, J.H. Evaluating the Patient Experience after Implantation of a 0.4 mg Sustained Release Dexamethasone Intracanalicular Insert (Dextenza TM ): Results of a Qualitative Survey. Patient Prefer. Adherence 2017 , 11 , 487–494. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Wilson, C.; Sall, K.N.; Bafna, S.; Gira, J.P.; McLaurin, E.B.; Protzko, E.; Sampson, R.; Tekwani, N.; Tepedino, M.; Vold, S.; et al. Results of A Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP (Travoprost Insert) Compared to Timolol Drops for the Treatment of Patients with Open-Angle Glaucoma or Ocular Hypertension. Investig. Ophthalmol. Vis. Sci. 2017 , 58 , 2111. [ Google Scholar ]
• Vantipalli, S.; Sall, K.N.; Stein, E.; Schenker, H.; Mulaney, J.; Smyth-Medina, R.; Day, D.; Benza, R.; Dixon, E.-R.; Rissman, N.; et al. Evaluation of the Safety and Efficacy of OTX-TP, an Intracanalicular Travoprost Insert, for the Treatment of Patients with Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 Study. Investig. Ophthalmol. Vis. Sci. 2020 , 61 , 3488. [ Google Scholar ]
• Goldberg, D.F.; Williams, R. A Phase 2 Study Evaluating Safety and Efficacy of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects with Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG). Investig. Ophthalmol. Vis. Sci. 2012 , 53 , 5095. [ Google Scholar ]
• Tost, F.H.; Geerling, G. Plugs for Occlusion of the Lacrimal Drainage System. Surg. Dry Eye 2008 , 41 , 193–212. [ Google Scholar ]
• Stout, N.; Harsch, A.G.; Lighthizer, N. Plug the Drain with Lacrimal Occlusion: Keep Dry Eye Patients Flowing into Your Office with This Time-Honored Technique. Rev. Optom. 2016 , 153 , 70–75. [ Google Scholar ]
• Macoul, K.L.; Pavan-Langston, D. Pilocarpine Ocusert System for Sustained Control of Ocular Hypertension. Arch. Ophthalmol. 1975 , 93 , 587–590. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Brandt, J.D.; Sall, K.; DuBiner, H.; Benza, R.; Alster, Y.; Walker, G.; Semba, C.P.; Budenz, D.; Day, D.; Flowers, B.; et al. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert. Ophthalmology 2016 , 123 , 1685–1694. [ Google Scholar ] [ CrossRef ]
• Brandt, J.D.; DuBiner, H.B.; Benza, R.; Sall, K.N.; Walker, G.A.; Semba, C.P.; Budenz, D.; Day, D.; Flowers, B.; Lee, S.; et al. Long-Term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring. Ophthalmology 2017 , 124 , 1565–1566. [ Google Scholar ] [ CrossRef ]
• Nair, R.V.; Shefrin, S.; Suresh, A.; Anoop, K.R.; Nair, S.C. Sustained Release Timolol Maleate Loaded Ocusert Based on Biopolymer Composite. Int. J. Biol. Macromol. 2018 , 110 , 308–317. [ Google Scholar ] [ CrossRef ]
• Kelly, J.A.; Molyneux, P.D.; Smith, S.A.; Smith, S.E. Relative Bioavailability of Pilocarpine from a Novel Ophthalmic Delivery System and Conventional Eye Drop Formulations. Br. J. Ophthalmol. 1989 , 73 , 360–362. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Greaves, J.; Wilson, C.; Birmingham, A.; Richardson, M.; Bentley, P. Scintigraphic Studies on the Corneal Residence of a New Ophthalmic Delivery System (NODS): Rate of Clearance of a Soluble Marker in Relation to Duration of Pharmacological Action of Pilocarpine. Br. J. Clin. Pharmacol. 1992 , 33 , 603–609. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Diestelhorst, M.; Krieglstein, G.K. The Ocular Tolerability of a New Ophthalmic Drug Delivery System (NODS). Int. Ophthalmol. 1994 , 18 , 1–4. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Bigdeli, A.; Makhmalzadeh, B.S.; Feghhi, M.; SoleimaniBiatiani, E. Cationic Liposomes as Promising Vehicles for Timolol/Brimonidine Combination Ocular Delivery in Glaucoma: Formulation Development and in Vitro/in Vivo Evaluation. Drug Deliv. Transl. Res. 2023 , 13 , 1035–1047. [ Google Scholar ] [ CrossRef ]
• Awwad, S.; Mohamed Ahmed, A.H.A.; Sharma, G.; Heng, J.S.; Khaw, P.T.; Brocchini, S.; Lockwood, A. Principles of Pharmacology in the Eye: Principles of Pharmacology in the Eye. Br. J. Pharmacol. 2017 , 174 , 4205–4223. [ Google Scholar ] [ CrossRef ]
• Pollack, I.P.; Quigley, H.A.; Harbin, T.S. The Ocusert Pilocarpine System: Advantages and Disadvantages. South. Med. J. 1976 , 69 , 1296–1298. [ Google Scholar ] [ CrossRef ]
• Uner, B.; Ozdemir, S.; Nur Pilevne, S.; Cenk Celebi, A.R. Timolol-loaded ethosomes for ophthalmic delivery: Reduction of high intraocular pressure in vivo. Int. J. Pharm. 2023 , 640 , 123021. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Cuggino, J.C.; Tártara, L.I.; Gugliotta, L.M.; Palma, S.D.; Alvarez Igarzabal, C.I. Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy. Mater. Sci. Eng. C Mater. Biol. Appl. 2021 , 118 , 111383. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Ilka, R.; Mohseni, M.; Kianirad, M.; Naseripour, M.; Ashtari, K.; Mehravi, B. Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma. Int. J. Biol. Macromol. 2018 , 109 , 955–962. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Cegielska, O.; Sierakowski, M.; Sajkiewicz, P.; Lorenz, K.; Kogermann, K. Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment. Eur. J. Pharm. Biopharm. 2022 , 180 , 48–62. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Agban, Y.; Lian, J.; Prabakar, S.; Seyfoddin, A.; Rupenthal, I.D. Nanoparticle Cross-Linked Collagen Shields for Sustained Delivery of Pilocarpine Hydrochloride. Int. J. Pharm. 2016 , 501 , 96–101. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Hiratani, H.; Alvarez-Lorenzo, C. Timolol Uptake and Release by Imprinted Soft Contact Lenses Made of N,N-Diethylacrylamide and Methacrylic Acid. J. Control. Release 2002 , 83 , 223–230. [ Google Scholar ] [ CrossRef ]
• Kim, J.; Conway, A.; Chauhan, A. Extended Delivery of Ophthalmic Drugs by Silicone Hydrogel Contact Lenses. Biomaterials 2008 , 29 , 2259–2269. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Peng, C.-C.; Burke, M.T.; Carbia, B.E.; Plummer, C.; Chauhan, A. Extended Drug Delivery by Contact Lenses for Glaucoma Therapy. J. Control. Release 2012 , 162 , 152–158. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Braga, M.E.M.; Costa, V.P.; Pereira, M.J.T.; Fiadeiro, P.T.; Gomes, A.P.; Duarte, C.M.M.; De Sousa, H.C. Effects of Operational Conditions on the Supercritical Solvent Impregnation of Acetazolamide in Balafilcon A Commercial Contact Lenses. Int. J. Pharm. 2011 , 420 , 231–243. [ Google Scholar ] [ CrossRef ]
• Jung, H.J.; Chauhan, A. Temperature Sensitive Contact Lenses for Triggered Ophthalmic Drug Delivery. Biomaterials 2012 , 33 , 2289–2300. [ Google Scholar ] [ CrossRef ]
• Peng, C.-C.; Ben-Shlomo, A.; Mackay, E.O.; Plummer, C.E.; Chauhan, A. Drug Delivery by Contact Lens in Spontaneously Glaucomatous Dogs. Curr. Eye Res. 2012 , 37 , 204–211. [ Google Scholar ] [ CrossRef ]
• Jung, H.J.; Abou-Jaoude, M.; Carbia, B.E.; Plummer, C.; Chauhan, A. Glaucoma Therapy by Extended Release of Timolol from Nanoparticle Loaded Silicone-Hydrogel Contact Lenses. J. Control. Release 2013 , 165 , 82–89. [ Google Scholar ] [ CrossRef ]
• Hsu, K.-H.; Carbia, B.E.; Plummer, C.; Chauhan, A. Dual Drug Delivery from Vitamin E Loaded Contact Lenses for Glaucoma Therapy. Eur. J. Pharm. Biopharm. 2015 , 94 , 312–321. [ Google Scholar ] [ CrossRef ]
• Ciolino, J.B.; Ross, A.E.; Tulsan, R.; Watts, A.C.; Wang, R.-F.; Zurakowski, D.; Serle, J.B.; Kohane, D.S. Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys. Ophthalmology 2016 , 123 , 2085–2092. [ Google Scholar ] [ CrossRef ]
• Wichterle, O.; Lím, D. Hydrophilic Gels for Biological Use. Nature 1960 , 185 , 117–118. [ Google Scholar ] [ CrossRef ]
• Muntz, A.; Subbaraman, L.N.; Sorbara, L.; Jones, L. Tear Exchange and Contact Lenses: A Review. J. Optom. 2015 , 8 , 2–11. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Sedlácek, J. Possibility of the application of ophthalmic drugs with the use of gel contact lenses. Ceskoslovenska Oftalmol. 1965 , 21 , 509–512. [ Google Scholar ]
• North, D.P. Treatment of Acute Glaucoma. Can. Med. Assoc. J. 1971 , 105 , 561. [ Google Scholar ]
• Uchida, R.; Sato, T.; Tanigawa, H.; Uno, K. Azulene incorporation and release by hydrogel containing methacrylamide propyltrimenthylammonium chloride, and its application to soft contact lens. J. Control. Release 2003 , 92 , 259–264. [ Google Scholar ] [ CrossRef ]
• Lovrec-Krstič, T.; Orthaber, K.; Maver, U.; Sarenac, T. Review of Potential Drug-Eluting Contact Lens Technologies. Materials 2023 , 16 , 3653. [ Google Scholar ] [ CrossRef ]
• Venkatesh, S.; Saha, J.; Pass, S.; Byrne, M. Transport and Structural Analysis of Molecular Imprinted Hydrogels for Controlled Drug Delivery. Eur. J. Pharm. Biopharm. 2008 , 69 , 852–860. [ Google Scholar ] [ CrossRef ]
• Yañez, F.; Martikainen, L.; Braga, M.E.M.; Alvarez-Lorenzo, C.; Concheiro, A.; Duarte, C.M.M.; Gil, M.H.; De Sousa, H.C. Supercritical Fluid-Assisted Preparation of Imprinted Contact Lenses for Drug Delivery. Acta Biomater. 2011 , 7 , 1019–1030. [ Google Scholar ] [ CrossRef ]
• Janagam, D.R.; Wu, L.; Lowe, T.L. Nanoparticles for Drug Delivery to the Anterior Segment of the Eye. Adv. Drug Deliv. Rev. 2017 , 122 , 31–64. [ Google Scholar ] [ CrossRef ]
• Xu, J.; Xue, Y.; Hu, G.; Lin, T.; Gou, J.; Yin, T.; He, H.; Zhang, Y.; Tang, X. A Comprehensive Review on Contact Lens for Ophthalmic Drug Delivery. J. Control. Release 2018 , 281 , 97–118. [ Google Scholar ] [ CrossRef ]
• Wang, M.T.M.; Ganesalingam, K.; Loh, C.S.; Alberquerque, T.; Al-Kanani, S.; Misra, S.L.; Craig, J.P. Compatibility of Phospholipid Liposomal Spray with Silicone Hydrogel Contact Lens Wear. Contact Lens Anterior Eye 2017 , 40 , 53–58. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Lim, C.H.L.; Stapleton, F.; Mehta, J.S. Review of Contact Lens–Related Complications. Eye Contact Lens Sci. Clin. Pract. 2018 , 44 , S1–S10. [ Google Scholar ] [ CrossRef ]
• Rouen, P.A.; White, M.L. Dry Eye Disease: Prevalence, Assessment, and Management. Home Healthc. Now 2018 , 36 , 74–83. [ Google Scholar ] [ CrossRef ]
• Stewart, W.C.; Garrison, P.M. β-Blocker–Induced Complications and the Patient With Glaucoma: Newer Treatments to Help Reduce Systemic Adverse Events. Arch. Intern. Med. 1998 , 158 , 221. [ Google Scholar ] [ CrossRef ]
• Raghava, S.; Hammond, M.; Kompella, U.B. Periocular routes for retinal drug delivery. Expert. Opin. Drug Deliv. 2004 , 1 , 99–114. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Natarajan, J.V.; Chattopadhyay, S.; Ang, M.; Darwitan, A.; Foo, S.; Zhen, M.; Koo, M.; Wong, T.T.; Venkatraman, S.S. Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye. PLoS ONE 2011 , 6 , e24513. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Natarajan, J.V.; Ang, M.; Darwitan, A.; Chattopadhyay, S.; Wong, T.T.; Venkatraman, S.S. Nanomedicine for Glaucoma: Liposomes Provide Sustained Release of Latanoprost in the Eye. Int. J. Nanomed. 2012 , 7 , 123–131. [ Google Scholar ] [ CrossRef ]
• Wong, T.T.; Novack, G.D.; Natarajan, J.V.; Ho, C.L.; Htoon, H.M.; Venkatraman, S.S. Nanomedicine for Glaucoma: Sustained Release Latanoprost Offers a New Therapeutic Option with Substantial Benefits over Eyedrops. Drug Deliv. Transl. Res. 2014 , 4 , 303–309. [ Google Scholar ] [ CrossRef ]
• Amrite, A.C.; Ayalasomayajula, S.P.; Cheruvu, N.P.S.; Kompella, U.B. Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE 2, VEGF, and Vascular Leakage. Investig. Ophthalmol. Vis. Sci. 2006 , 47 , 1149. [ Google Scholar ] [ CrossRef ]
• Amrite, A.C.; Kompella, U.B. Size-Dependent Disposition of Nanoparticles and Microparticles Following Subconjunctival Administration. J. Pharm. Pharmacol. 2010 , 57 , 1555–1563. [ Google Scholar ] [ CrossRef ]
• Nagai, N.; Tsukamoto, A.; Kotake, T.; Ito, Y.; Okamoto, N.; Shimomura, Y. Evaluation of Rabbit Model for Glaucoma Study: Drug Interaction in a Rabbit Model Instilled with Ophthalmic Preparation containing Latanoprost and Timolol. Iryo Yakugaku (Jpn. J. Pharm. Health Care Sci.) 2016 , 42 , 645–650. [ Google Scholar ] [ CrossRef ]
• Gautam, M.; Gupta, R.; Singh, P.; Verma, V.; Verma, S.; Mittal, P.; Karkhur, S.; Sampath, A.; Mohan, R.R.; Sharma, B. Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes. J. Ocul. Pharmacol. Ther. 2023 , 39 , 102–116. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Bacharach, J.; Tatham, A.; Ferguson, G.; Belalcázar, S.; Thieme, H.; Goodkin, M.L.; Chen, M.Y.; Guo, Q.; Liu, J.; Robinson, M.R.; et al. ARTEMIS 2 Study Group. Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2). Drugs 2021 , 81 , 2017–2033. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Medeiros, F.A.; Walters, T.R.; Kolko, M.; Coote, M.; Bejanian, M.; Goodkin, M.L.; Guo, Q.; Zhang, J.; Robinson, M.R.; Weinreb, R.N.; et al. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1). Ophthalmology 2020 , 127 , 1627–1641. [ Google Scholar ] [ CrossRef ]
• Berdahl, J.P.; Sarkisian, S.R., Jr.; Ang, R.E.; Doan, L.V.; Kothe, A.C.; Usner, D.W.; Katz, L.J.; Navratil, T.; Travoprost Intraocular Implant Study Group. Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension. Drugs 2024 , 84 , 83–97. [ Google Scholar ] [ CrossRef ]
• Sirinek, P.E.; Lin, M.M. Intracameral Sustained Release Bimatoprost Implants (Durysta). Semin. Ophthalmol. 2022 , 37 , 385–390. [ Google Scholar ] [ CrossRef ]
• Stamer, W.D.; Perkumas, K.M.; Kang, M.H.; Dibas, M.; Robinson, M.R.; Rhee, D.J. Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant. Investig. Ophthalmol. Vis. Sci. 2023 , 64 , 15. [ Google Scholar ] [ CrossRef ]
• Medeiros, F.A.; Sheybani, A.; Shah, M.M.; Rivas, M.; Bai, Z.; Werts, E.; Ahmed, I.I.K.; Craven, E.R. Single Administration of Intracameral Bimatoprost Implant 10 mg in Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmol. Ther. 2022 , 11 , 1517–1537. [ Google Scholar ] [ CrossRef ]
• Belamkar, A.; Harris, A.; Zukerman, R.; Siesky, B.; Oddone, F.; Verticchio Vercellin, A.; Ciulla, T.A. Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications. Ann. Med. 2022 , 54 , 343–358. [ Google Scholar ] [ CrossRef ]
• Miller, P.E.; Eaton, J.S. Medical Antiglaucoma Therapy: Beyond the Drop. Vet. Ophthalmol. 2021 , 24 , 2–15. [ Google Scholar ] [ CrossRef ]

Click here to enlarge figure

Share and Cite

Fea, A.M.; Vallino, V.; Cossu, M.; Marica, V.; Novarese, C.; Reibaldi, M.; Petrillo, F. Drug Delivery Systems for Glaucoma: A Narrative Review. Pharmaceuticals 2024 , 17 , 1163. https://doi.org/10.3390/ph17091163

Fea AM, Vallino V, Cossu M, Marica V, Novarese C, Reibaldi M, Petrillo F. Drug Delivery Systems for Glaucoma: A Narrative Review. Pharmaceuticals . 2024; 17(9):1163. https://doi.org/10.3390/ph17091163

Fea, Antonio M., Veronica Vallino, Michela Cossu, Valentina Marica, Cristina Novarese, Michele Reibaldi, and Francesco Petrillo. 2024. "Drug Delivery Systems for Glaucoma: A Narrative Review" Pharmaceuticals 17, no. 9: 1163. https://doi.org/10.3390/ph17091163

Article Metrics

Article access statistics, further information, mdpi initiatives, follow mdpi.

Subscribe to receive issue release notifications and newsletters from MDPI journals

Chapter 2: Review of Related Literature in Pharmacy Management System

This article about Chapter 2: Review of Related Literature in Pharmacy Management System will give you the following ideas how to create the chapter of pharmacy management system that focus on review of related literature.

Pharmacy Management System Thesis Chapter 2

REVIEW OF RELATED LITERATURE AND PRIOR ARTS

Local related literature, the importance of sales monitoring with your cable tv.

According to Villanueva (2015), from the book The Importance of Sales Monitoring with Your Cable TV , Monitoring of sales whenever it comes to doing business online is very vital. To be able to make sure that everything is in order, it has to practice monitoring. It is because monitoring is important in a business one must hire a person who is loyal and trustworthy. Otherwise the online business will fall apart in a matter of time. One of the modus operandi commonly practiced is the falsification of sales and revenue reports by the person trusted by the owner. A part of the total sales might be pocketed. You cannot have a hundred percent assurance that the sales reported back to you are valid.

In this citation it says that monitoring of sales is essential in every business. Without proper monitoring a business my fall apart due to falsification of sales and revenue reports. Monitoring of sales helps the owner of the business to keep track of sales and ensure that the sales reports are valid.

Medicines management

According to Dan Brian (2011) a lot of the websites we visit nowadays are testing and requiring that we create so-called “strong” passwords. Unfortunately, it is not a practice that every site accommodates, whether because it has not update, edits code to meet these most recent standards, or simply because it lacks the resources to do so. It is then up to the user to create its own personal “Security Best Practices”.

Foreign Related Literature

Records management, system analysis and design.

According to Hold (2010) article, “Inventory refers to stocks of anything necessary to do business”. The U.S Small Business Administration publication describes what constitutes successful inventory management balancing cost versus benefits of inventory, including: Maintaining a wide assortment without sacrificing service; Keeping stock low without sacrificing performance; Obtaining lower prices by making volume purchases; and Maintaining an adequate inventory without an excess of obsolete items. (Espinosa, n.d.)

Local Related System

Development and evaluation of a computerized sales and inventory system of mother’s best company.

By understanding the Strength and Weaknesses of people and technologies you have opportunity to design the process that best utilize the strength of each to offset inherent weaknesses as said by Piaseki(2009) from his book entitle, Inventory Accuracy : People Process and Technology.

Supplies and Inventory System

Inventory system is a simple system that keeps track of the item received and items issued. The similarities of the proposed system to the Supplies and Inventory System

­­ Sales and Inventory Monitoring System

      A sales and inventory monitoring system collects data to aid in production scheduling, accurate details, and reliable information. For example, some systems use recent sales data to forecast how many of a type of product will be needed to meet consumer demand in the near future. This includes monitoring the levels of a product at all locations. A good example is a global company with customers all over the world. The customer may live in Philippines, but the system must see if the warehouse in China has a product available to ship to Philippines. The similarities of the proposed system to the Sales and Inventory Monitoring Systemare almost the same in terms of Automated System, Connectivity, Platforms (PC or Android), and Point of Sale.

Foreign Related System

Pharmacy inventory management system.

According to King Saud Bin Abdulaziz  (2015), the preliminary findings of the implementation process of a pharmacy inventory management system at a local Saudi hospital. Meeting documents, key informant interviews, and experience of the researcher were part of the data collection sources used in the study. A thematic analysis of the data was conducted. Preliminary findings show that the implementation process of the pharmacy inventory management system needs the involvement and support of senior management and experienced technical expertise. Future research will focus on investigating the impacts of the pharmacy inventory management system on workflow and medication errors. The similarities of the proposed system to the Pharmacy Inventory Management System are almost the same in terms of Automated System, Connectivity, Platforms (PC or Android), and Point of Sale.

Computerized Payroll System

Computer based system.

As a stated at the book of Passion (2011 ), to improve their efficiency and reduce their cost of operation. Reports are more timely and accurate. Computers have a large capacity to store data and tremendous speed to manipulate and recall data to the format a user wished to use which introduction of microcomputer computation of business is more affordable (Espinosa, n.d.). The similarities of the proposed system to the Computer Based System are almost the same in terms of Automated System, Connectivity, Platforms (PC or Android), Point of Sale, and Payroll.

Table 1. Features and Comparison of Foreign and Local System

Download the Full Source Code of this project

Related article, leave a comment cancel reply.